Functional analysis of TOR complex 2 and its control of sphingolipid biosynthesis in "Saccharomyces cerevisiae" by Shioda, Ryo
 Functional analysis of TOR complex 2 and its 
control of sphingolipid biosynthesis in 
Saccharomyces cerevisiae 
 
Inauguraldissertation 
Zur 
 Erlangung der Würde eines Doktors der Philosophie 
vorgelegt der 
Philosophisch-Naturwissenschaftlichen Fakultät Der Universität Basel 
von 
 
Ryo Shioda 
aus Japan 
 
Leiter der Dissertation: Prof Dr Michael N. Hall 
 
Basel 
Juni 2006 
Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät  
auf Antrag von 
Prof. Dr. M. N. Hall, und Prof Dr. M. Spiess  
 
Basel, den 20. Juni 2006 
 
 1
Summary 
The target of rapamycin (TOR) kinase is a central controller of cell growth. In yeast, the 
TOR proteins function as key components of two highly conserved multiprotein 
complexes, TORC1 and TORC2.  TORC1 is sensitive to the immunosuppressive and 
anti-cancer drug rapamycin, and controls temporal aspects of cell growth through 
regulation of transcription and translation.  It contains TOR1 or TOR2, and in addition 
KOG1, LST8, and TCO89.  TORC2 is a rapamycin insensitive complex that mediates 
spatial control of cell growth via actin cytoskeleton organization.  It contains TOR2, 
AVO1, AVO2, AVO3, BIT61 and LST8.  
This thesis has two parts.  In the first part, we describe a molecular analysis of the 
TORC2 subunit AVO3.  We find that AVO3 is localized at the cell periphery, consistent 
with the localization of TOR2.  AVO3 has six distinct regions that are highly 
conserved from yeast to human.  AVO3 and, in particular, five of its conserved regions 
are required for the TORC2 function of signaling via the cell integrity pathway and 
polarization of the actin cytoskeleton.   AVO3 also interacts with the novel TORC2 
component BIT2, and is required for full activation of the TORC2 downstream target 
MPK1.  This part of the thesis therefore describes a positive role for AVO3 in TORC2, 
to support growth and actin organization.   
In the second part of this thesis, we focus on a new readout of TORC2, crosstalk with 
the sphingolipid biosynthesis pathway.  Sphingolipids and their metabolites are known 
as building components of cellular membranes, and also as signaling molecules 
mediating cell growth, endocytosis, actin regulation, and stress response.  Here we 
show that TORC2 temperature sensitive mutants, tor2ts and avo3-1, are synthetically 
lethal at the permissive temperature, with partial inhibition of sphingolipid biosynthesis 
by the antibiotic myriocin.  At non-permissive temperature, the TORC2 mutants show 
reduced de novo synthesis of sphingolipids.  Consistent with this, a general reduction 
of sphingolipid contents is also observed in steady state.  In contrast, rapamycin 
treatment and loss of TORC1 function do not induce a reduction in sphingolipid 
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biosynthesis.  Our findings in this part of the thesis indicate that TORC2, but not 
TORC1, mediate sphingolipid biosynthesis.  
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Preface 
This thesis focuses mainly on functional analysis of TOR complex 2 (TORC2) in yeast 
Saccharomyces cerevisiae.  As a result, many exciting findings concerning TOR 
complex 1 (TORC1) are overlooked in this thesis, even though the importance of 
TORC1 on cell growth is recognized.    
As the mammalian TORC1 field has been tugged by findings in yeast TORC1, so could 
the findings in yeast TORC2 contribute to understanding of the structure and function of 
mammalian TORC2.   
This thesis is divided into three parts.  The first part, the introduction, provides an 
overview of the two major players of this thesis, yeast TORC2 signaling pathway and 
sphingolipid biosynthetic pathway.   
The second part, the results, represents two major findings that were made during this 
study.  The first key finding was that AVO3, a component of TORC2, is essential for 
TORC2 function.  The second was that TORC2 signaling pathway controls 
sphingolipid biosynthesis.  This study was carried out in close collaboration with 
Karsten Meyer and the help of Xue Li Guan, and Markus R. Wenk at Singapore.  
In the last part, based on our findings and results as well as those of other labs, the 
functions of TORC2 are discussed in a broader context.  Although this part is 
hypothetical, it gives some perspective to understanding the “TORC2 network”.  
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Introduction 
Cell growth is a fundamental property of cells 
Cell growth, defined as accumulation of cell mass, is a fundamental property of cells, 
together with cell division and cell death.  Cell growth and cell division are considered 
to be distinct processes.  During formation of egg and neuronal spiral code, for 
example, cells accumulate cell mass without dividing.  On the other hand, during egg 
cleavage, cells divide without any accumulation of cell mass.  These examples clearly 
show that the two fundamental processes, cell growth and cell division, are distinct.  
Since cell growth governs cell size, it must be tightly regulated.   Imagine a cell that 
its size decreases its size 0.98 times during the cell cycle.  The cell would become 
smaller than a single atom after several thousand cell cycles.  Imagine a cell that 
increases its size 1.02 times during cell cycle.  The cell would be larger than the earth 
after several thousand cell cycles.  Thus, similar to cell division, cells have specific 
mechanisms that regulate accumulation of mass.   
Cell growth implicates mass accumulation and 
surface expansion 
Mass accumulation during cell growth is accompanied by expansion of cell surface, i.e. 
plasma membrane.  Mathematically, when the cubic volume of an ideal sphere is 
doubled, the surface area is increased 1.69 times; therefore cells need to synthesize a 
sufficient quantity of lipids during each cell growth period.  In addition to the plasma 
membrane, cells contain other membrane systems, such as mitochondria, Golgi, 
endoplasmic reticulum, and other vesicles which are also required for duplication.  In 
other words, cells have to coordinate synthesis of those membranes, and particularly 
synthesis of lipids, with cell growth.  Thus, cells most likely have a system(s) that 
regulates lipid biogenesis.   
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TOR as a central controller of cell growth 
The target of rapamycin 
The target of rapamycin protein, TOR, plays a key role in the regulation of cell growth.  
TOR was originally identified in Saccharomyces cerevisiae as a mutant that is resistant 
to rapamycin, a drug known as immunosuppressant, anti-proliferative, and anti-cancer 
agent (Heitman, Movva et al. 1991).   TOR is a structurally and functionally 
conserved in eukaryotes.  It contains a kinase domain which has strong similarity to 
the catalytic domains of phosphoinositide-3 kinase (PI3K) and phosphatidylinositol-4 
kinase (PI4K) (Fruman, Meyers et al. 1998; Crespo and Hall 2002).  Two other 
conserved domains, HEAT repeats and FAT domain, are involved in mediating protein 
interaction.  Functionally, TOR regulates cell growth in response to nutrients.  
TOR complex 1 as a temporal controller of cell growth 
The TOR proteins in Saccharomyces cerevisiae are part of two distinct multiprotein 
complexes: TOR complex 1 (TORC1) and TOR complex 2 (TORC2) (Loewith, Jacinto 
et al. 2002; Wedaman, Reinke et al. 2003; Reinke, Anderson et al. 2004).  The activity 
of both TOR proteins depends on formation of these complexes (Wullschleger, Loewith 
et al. 2005).   
In response to nutrients, TORC1, which contains TOR1 or TOR2 (and is therefore 
termed “the shared pathway”), and associated partners KOG1, TCO89, and LST8, plays 
an essential role in temporal control of cell growth.  TORC1 positively controls 
starvation-specific transcription and translation via a phosphatase switch composed of 
the type 2A-related phosphatase SIT4, TAP42, and TIP41 (Di Como and Arndt 1996; 
Jiang and Broach 1999; Jacinto, Guo et al. 2001; Cherkasova and Hinnebusch 2003).  
Under good nitrogen conditions, TOR inactivates the type 2A-related phosphatase SIT4 
by binding SIT4 to TAP42 (Di Como and Arndt 1996; Jiang and Broach 1999; Jacinto, 
Guo et al. 2001).  In the absence of nutrients, TORC1 is inactive and mediate release 
of SIT4 from TAP42.  Released, and therefore active SIT4, dephosphorylates and 
activates target proteins such as the transcription factor GLN3 and the kinase NPR1, 
which are involved in synthesizing alternative nutrient sources (Beck and Hall 1999; 
Jacinto, Guo et al. 2001).  TOR also mediates ribosomal protein gene transcription, by 
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regulating the subcellular localization of a corepressor CRF1 via protein kinase A 
(PKA) and the PKA-regulated kinase YAK1 (Martin, Soulard et al. 2004).  In addition, 
TOR regulates autophagy, by controlling ATG1 kinase-dependent organization of 
elements on the pre-autophagosomal membrane (Mizushima, Yamamoto et al. 2001; 
Suzuki, Kirisako et al. 2001; Kim, Huang et al. 2002).   
Mammalian TOR complex 1 (mTORC1) controls several pathways that collectively 
determine the cell mass.  mTORC1 acts as an assembler of growth signals, such as 
growth hormones, amino acids availability, and energy, and regulates several cellular 
processes including translation, transcription, ribosome biosynthesis, and autophagy 
(Hay and Sonenberg 2004; Wullschleger, Loewith et al. 2006).  mTORC1 is sensitive 
to rapamycin, and consists of mTOR, raptor, and mLST8, which are the mammalian 
homologs of TOR1/TOR2, KOG1 and LST8, respectively (Hara, Maruki et al. 2002; 
Kim, Sarbassov et al. 2002).  
TOR complex 2 as a spatial controller of cell growth 
While TORC1 is responsible for temporal control of cell growth, TORC2 signaling 
pathway mediates a spatial control of cell growth, including actin cytoskeleton 
organization and regulation of endocytosis in a cell-cycle dependent manner.  TORC2 
is rapamycin insensitive complex.  Intensive work on TORC2 and its downstream 
targets have revealed parts of this complex signaling network, however there is still 
much unknown.  The TORC2 and its downstream cascades are drawn in Figure I-1. 
 11
 
Figure I-1. The TOR complex 2 signaling network.   
“P” indicates phosphorylation.  See text for detail.  
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TORC2 in S. cerevisiae 
Yeast TOR2, as well as TOR1, are ~280 KDa proteins that contain several domains.  
An N-terminal domain comprised of up to 20 tandem-repeated HEAT motifs, that 
mediate protein-protein interactions in multiprotein complexes (Groves and Barford 
1999).  The FAT domain, occupying the region between the HEAT repeats and a 
C-terminal catalytic domain, also mediates protein-protein interactions, and perhaps 
also acts as a scaffold.  In addition, based on gel filtration elution profile, TOR2 
appears as two species, one of 1.5–2 MDa and a second of 0.7–0.8 MDa (Loewith, 
Jacinto et al. 2002; Wullschleger, Loewith et al. 2005).  Consistent with the findings 
above, TOR2 is indeed found in a multiprotein complex (Loewith, Jacinto et al. 2002; 
Wedaman, Reinke et al. 2003; Reinke, Anderson et al. 2004).  TORC2 is composed of 
TOR2, but not TOR1 (and is therefore termed “the unique pathway”), AVO1, AVO2, 
AVO3, LST8, BIT61, BIT2, SLM1, and SLM2 (Loewith, Jacinto et al. 2002; Wedaman, 
Reinke et al. 2003; Audhya, Loewith et al. 2004; Fadri, Daquinag et al. 2005).  The 
complex mediates actin cytoskeleton organization, and therefore is essential for spatial 
control of cell growth (Loewith, Jacinto et al. 2002).   
TOR2, LST8, AVO1, and AVO3 are essential genes.  SLM1 and SLM2 are redundant 
and perform an essential function, since a double deletion mutant is lethal (Audhya, 
Loewith et al. 2004).  Consistent with the phenotypes of TOR2-depleted cell, LST8-, 
AVO1-, and AVO3-depleted cells exhibit a depolarized actin cytoskeleton and show cell 
cycle arrest at G2/M transition (Loewith, Jacinto et al. 2002; Ho, Shiau et al. 2005).  
AVO2, BIT61, and BIT2 are non-essential genes, and deletion mutants do not show any 
phenotype under good nutrient conditions.  Function of the partner proteins is not 
well-characterized except contribution to TORC2 kinase activity (Wullschleger, 
Loewith et al. 2005). 
Downstream targets of TORC2 in yeast 
ROM2, RHO, PKC1, and MPK1-MAP kinase cascade 
The TORC2 signaling pathway begins with activation of the guanine nucleotide 
exchange factor ROM2 by an unknown mechanism (Schmidt, Bickle et al. 1997).  
Activated ROM2 in turn converts small GTPase RHO1 and RHO2 to their active, GTP 
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bound state.  GTP-bound RHO can bind and phosphorylate PKC1 (Kamada, Qadota et 
al. 1996).  PKC1 regulates organization of the actin cytoskeleton via the MPK1-MAP 
kinase cascade (Schmidt, Bickle et al. 1997; Helliwell, Howald et al. 1998; Loewith, 
Jacinto et al. 2002).  The MPK1-MAP kinase cascade composes of MAPKKK, BCK1, 
two redundant threonine/tyrosine MAPKKs, MKK1 and MKK2, and the MAPK 
MPK1/SLT2 (Costigan, Gehrung et al. 1992; Nonaka, Tanaka et al. 1995; Kamada, 
Qadota et al. 1996; Delley and Hall 1999).   
It is known that the MPK1-MAP kinase cascade mainly maintains cell integrity by 
regulating cell wall biosynthesis in response to stresses (Levin 2005).  MPK1 is 
activated by dual phosphorylation of its two conserved theronine (Thr190) and tyrosine 
(Tyr192) residues (Lee, Irie et al. 1993).  The activated-MPK1 induces transcription of 
genes involved in cell wall biosynthesis such as CHS3, encoding a chitin synthase, and 
FKS1, a component of β-1,3-glucan synthase (Jung and Levin 1999).  RLM1 and 
SWI4 are identified as the transcription factors of MPK1 (Watanabe, Takaesu et al. 
1997; Garcia, Bermejo et al. 2004; Levin 2005).  RLM1 up-regulates expression of 
cell wall-related genes.  RLM1 interacts with MPK1 for activation by phosphorylation 
(Watanabe, Irie et al. 1995; Jung, Sobering et al. 2002).  However, loss of MPK1 
function leads to more severe phenotypic defects than a rlm1 deletion mutant, 
suggesting that MPK1 has additional effectors (Jung and Levin 1999).  SWI4 is the 
transcription factor of the SWI4-SWI6 complex that regulates late G1-specific 
transcription targets.  SWI6 is a transcription cofactor of SWI4, and phosphorylated in 
vivo in an MPK1-dependent manner in response to cell wall stress (Madden, Sheu et al. 
1997).  Interestingly, the cell cycle regulated phosphorylation site of SWI6, Ser160, is 
within a consensus MAP kinase phosphorylation site, and a swi6 mutant that lacks this 
site is not phosphorylated by MPK1 (Baetz, Moffat et al. 2001). This suggests that 
MPK1 may regulate the SWI4-SWI6 complex through the cell cycle.  Consistent with 
this notion is the fact that MPK1 activity fluctuates through the cell cycle, peaking in G1 
(Zarzov, Mazzoni et al. 1996).  It is also unknown how MPK1 mediates actin 
cytoskeleton organization.   
MAPK phosphatases 
As the phosphorylation cascades of MAP kinases positively regulate their activity, 
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dephosphorylation of MAP kinases plays an important role in their regulation.  MAPK 
phosphatases remove a phosphate from phospho-tyrosine and/or phospho-threonine 
residues of MAP kinases, and thereby downregulate the activity of MAP kinases.  
MSG5 is a dual-specificity (Tyr and Ser/Thr) protein phosphatase involved in regulation 
of the MPK1 activity.  MSG5 was originally isolated as a suppressor of G1 cell cycle 
arrest induced by pheromone-stimulation and disruption of GPA1, α subunit of G 
protein coupled to mating factor receptors (Doi, Gartner et al. 1994).  Overexpression 
of MSG5 suppresses the growth-inhibitory effect of overexpression of MKK1P386, an 
activated-form of MKK1 MAPK kinase (Watanabe, Irie et al. 1995).  In contrast, 
disruption of MSG5 increases the phosphorylation state of MPK1 upon heat shock 
(Martin, Rodriguez-Pachon et al. 2000; Flandez, Cosano et al. 2004).  MSG5 binds 
and dephosphorylates MPK1.   Reciprocally, MPK1 phosphorylates MSG5 as a 
consequence of the activation of MPK1.  Under activating conditions, a decrease in the 
affinity between MSG5 and MPK1 is observed, suggesting that the mechanism by 
which MPK1 controls MSG5 is via the modulation of protein-protein interactions.  
The other MAPK phosphatases, such as PTP2, PTP3, and SDP1, are also known to act 
on MPK1, and are required in a passive way to provide basal signal to the MAP kinase 
(Theodosiou and Ashworth 2002).   
YPK1 and YPK2 
YPK1 and YPK2 were originally isolated as genes which share 44-46% identity with 
mammalian PKC isozymes throughout their putative catalytic domains (Chen, Lee et al. 
1993).  Double deletion mutant ypk1 ypk2 is lethal.  Expression of rat serum- and 
glucocorticoid-inducible kinase (SGK) can rescue the ypk1 ypk2 mutant, but other AGC 
kinases, such as mouse protein kinase B (PKB) or rat p70 S6 kinase, can not suppress 
the lethality, suggesting that yeast YPK function similarly to mammalian SGK 
(Casamayor, Torrance et al. 1999).   
YPK kinases are phosphorylated by TOR2 and PKH kinases (Roelants, Torrance et al. 
2002; Kamada, Fujioka et al. 2005; Liu, Zhang et al. 2005).  TOR2 directly 
phosphorylates the turn motif and the hydrophobic motif of YPK2, and regulates YPK2 
kinase activity, which is required for regulation of actin organization(Kamada, Fujioka 
et al. 2005).   PKH kinase, PKH1 and PKH2, are yeast orthologues of the mammalian 
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PDK1 protein kinase.  PKH kinases phosphorylate the conserved residue Thr501 in 
YPK2 (Casamayor, Torrance et al. 1999), which is also required for endocytosis and 
actin organization (Friant, Lombardi et al. 2001; deHart, Schnell et al. 2002).  PKH 
kinases are activated by sphingoid bases, and phosphorylate YPK kinases and PKC1 
(Friant, Lombardi et al. 2001; Roelants, Torrance et al. 2002; Liu, Zhang et al. 2005).   
Loss of YPK1 alone is sufficient to cause slow growth and a defect in the depolarization 
of the actin cytoskeleton (Chen, Zheng et al. 1995; Roelants, Torrance et al. 2002; 
Schmelzle, Helliwell et al. 2002).  These defects are suppressed by overexpression of 
the Rho GEF TUS1, or expression of activated-PKC1 (Roelants, Torrance et al. 2002; 
Schmelzle, Helliwell et al. 2002).  In addition, YPK deficient cells are defective in 
MAP kinase activation in response to heat shock, indicating that YPK proteins mediate 
actin cytoskeleton organization via the MPK1-MAP kinase cascade (Schmelzle, 
Helliwell et al. 2002).  Another downstream target of YPK proteins is a type I myosin 
MYO5 (Grosshans, Grotsch et al. 2006).  Deletion of MYO5 has little effect on growth, 
but together with a deletion of MYO3, encoding the other type I myosin, severe defect in 
growth, actin cytoskeleton organization, and endocytosis are observed (Geli and 
Riezman 1996; Anderson, Boldogh et al. 1998; Jonsdottir and Li 2004).  MYO5 
interacts with YPK2, and its myosin motor domain is phosphorylated by YPK2 in vitro.  
In addition, a deletion of MYO5 causes a synthetic α-factor uptake defect in a YPK2 
deletion mutant (Grosshans, Grotsch et al. 2006).  MYO5 also interacts with PKH1 
and PKH2, and a MYO5 deletion mutant shows synthetic growth defect in a PKH 
deficient cells (Grosshans, Grotsch et al. 2006).  These results suggest that YPK 
kinases and probably PKH kinases directly control MYO5 activity that modulates actin 
cytoskeleton and endocytosis.   
In summary, YPK kinases act as an effecter of TORC2 and PKH kinases, and mediate 
actin cytoskeleton organization and endocytosis together with MPK1-MAP kinase 
cascade and the type I myosins.   
SLM1 and SLM2 
SLM1 and SLM2 were originally identified as interacting proteins of AVO2 by a global 
two-hybrid screening (Uetz, Giot et al. 2000).  The screening has also provided an 
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interesting connection; SLM1 and SLM2 can also interact with AVO3 via BIT2.  
SLM1 and SLM2 are 53%indentical and functionally redundant proteins, but expression 
levels of SLM1 is about 10 times higher that those of SLM2 (Audhya, Loewith et al. 
2004).  Both proteins contain Pleckstrin homology (PH) domains, which are known for 
their ability to bind phosphoinositides and to drive membrane recruitment of their host 
proteins.   
Disruption mutant of SLM1 is synthetic lethal with mss4ts, a temperature sensitive 
mutant of a single phosphoinositide kinase in yeast (Audhya, Loewith et al. 2004).  
This genetic interaction is interesting because overexpression of MSS4 is a suppressor 
of tor2ts (Helliwell, Howald et al. 1998).  Double deletion mutant slm1 slm2 is lethal.  
Lethality of the double deletion mutant can be suppressed by additional deletion of 
SAC7, a RHO1 guanine nucleotide activating protein, both at permissive and 
non-permissive temperature, suggesting that elevated RHO1-GTP levels are sufficient 
to bypass the requirement for SLM1 and SLM2 for cell viability (Audhya, Loewith et al. 
2004).  SLM temperature sensitive strains, slm1ts slm2∆, show actin depolarization and 
the depolarization of actin is suppressed by overexpression of PKC1 (Audhya, Loewith 
et al. 2004; Fadri, Daquinag et al. 2005).  SLM1 and SLM2 are phosphorylated by 
TORC2 protein kinase activity in vitro, and phosphorylation of SLM proteins requires 
TORC2 protein kinase activity in vivo.  In tor2ts strain, SLM1 does not localize the cell 
periphery where SLM1 in the wild type localizes.  Thus these data suggest that SLM1 
and SLM2 act on downstream of TORC2 in signaling to the actin cytoskeleton, and 
represent the first substrates of TORC2 protein kinase activity (Audhya, Loewith et al. 
2004).  
Recently, it was proposed that SLM1 and SLM2 are substrates of the calcineurin 
phosphatase required for heat stress-induced endocytosis of the yeast uracil permease 
FUR1 (Bultynck, Heath et al. 2006).  SLM1 and SLM2 lacking the calcineurin 
recognition site is unable to be dephosphorylated, and the phosphorylated SLM proteins 
accumulate in time dependent manner upon heat stress.  This phosphorylation is also 
observed in tor2ts mutant, suggesting that phosphorylation of SLM proteins upon heat 
stress are carried out by other kinases.  During heat shock, YPK and PKH kinases are 
activated by sphingolipid intermediates phytosphingosine (Friant, Lombardi et al. 2001).  
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Inhibition of whole sphingolipid biosynthesis by antibiotic myriocin demonstrates less 
phosphorylation of SLM proteins, indicating that certain kinases activated 
phytosphingosine are required for phosphorylation of SLM proteins (Bultynck, Heath et 
al. 2006).   
Taken together, SLM proteins could play a role in an effecter of TORC2 signaling, 
phosphoinositide signaling, and stress response cascade, and mediates actin 
cytoskeleton organization.   
TORC2 readouts  
Actin cytoskeleton organization 
The actin cytoskeleton organization is a well-established readout of TORC2.  In 
Saccharomyces cerevisiae, there are three distinct structures of actin, actin cables, an 
actinmyosin contractile ring, and cortical patches (Adams and Pringle 1984; Pruyne and 
Bretscher 2000).  Actin cables, composed of actin (ACT1), fimbrin (SAC6), and 
tropomyosin (TPM1, TPM2), is organized in parallel towards the incipient and growing 
bud (Pruyne and Bretscher 2000).  The cables serve as tracks for myosin V–based 
transport system that delivers vesicles, organelles and mRNA to the bud.  The 
actin-myosin contractile ring transiently forms at the mother-daughter neck and is 
important for cytokinesis.  Actin patches are associated with invaginations of the 
plasma membrane and are composed of filamentous actin and many other proteins 
(Mulholland, Preuss et al. 1994; Pruyne and Bretscher 2000).  These structures appear 
at the cortex with a short lifetime (5 to 20 sec) (Smith, Swamy et al. 2001; Kaksonen, 
Sun et al. 2003) and are highly motile (Doyle and Botstein 1996; Waddle, Karpova et al. 
1996; Carlsson, Shah et al. 2002; Kaksonen, Sun et al. 2003).   The actin cytoskeleton 
carries out reconstruction and provides mechanical strength in response to changes in 
the external environment, and is also implicated in various other cellular processes 
(Pruyne and Bretscher 2000; Pruyne and Bretscher 2000).  In addition, both cables and 
patches change their arrangement in a cell cycle-dependent manner.  The cortical 
patches, for instance, localize to the cell periphery during the S phase, and to the small 
and growing bud during the G2/M phase (Casamayor and Snyder 2002).  The functions 
of actin patches are not clearly defined, but they are likely to act on part of endocytic 
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events.  
Endocytosis  
Several reports have argued that TOR is involved in endocytosis (deHart, Schnell et al. 
2003; Schmelzle, Beck et al. 2004).  Endocytosis plays a key role not only in uptake of 
nutrients and pathogens from extracellular environment, but also in control of the 
protein and lipid composition of the plasma membrane and regulation of signaling 
pathways.  Endocytosis requires remodeling of the cell cortex during its internalization, 
i.e. invagination of the plasma membrane induced by endocytic coat proteins.  In 
addition, actin cytoskeleton organization, especially actin cortical patches, plays a 
critical role in endocytic internalization (Engqvist-Goldstein and Drubin 2003).  It can 
be suspected that TOR has a linkage to endocytosis via actin cytoskeleton control.   
Indeed, Hicke and colleagues isolated a TOR2 mutant tor2G2128R which has defect in 
endocytosis.  α-factor internalization in tor2G2128R cells was significantly delayed 
compared with TOR2 wild type cells (deHart, Schnell et al. 2002), and Lucifer yellow 
uptake to the vacuole in the mutant was not be observed (deHart, Schnell et al. 2003).  
In the mutant cells, actin was frequently depolarized, with actin patches seen throughout 
the mother cell, instead of polarized towards the bud.   
Consisted with tor2G2128R results, disruption of rom2, a downstream target of TOR2, 
also decreased efficiency of α-factor internalization (deHart, Schnell et al. 2003).  A 
mutant of ypk1, another down stream target of TOR2 (Kamada, Fujioka et al. 2005), 
was also identified as defective in α-factor internalization through ROM2-RHO1 
(deHart, Schnell et al. 2002; deHart, Schnell et al. 2003), suggesting that YPK1 is 
required for receptor internalization.  All of the findings described above indicate that 
TOR2 could be involved in endocytosis in yeast. 
TORC2 in other species  
Currently, mammalian TORC2 (mTORC2) and Dictyostelium TORC2 are only 
identified.  However, Drosophila, Candida Sp., Ashbya gossypii, Schizosaccharomyces 
pombe have a putative homolog of AVO3.  There is possibility that these species 
posses a functionally and structurally equivalent complex to TORC2.  AVO3 homolog 
is not found yet in plants and C. elegance.  
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Mammalian 
Mammalian TOR complex 2 (mTORC2) is proposed to mediate actin cytoskeleton 
organization like the yeast TORC2.  mTORC2 contains mTOR, rictor (also known as 
mAVO3), and mLST8, orthologs of the yeast TOR2, AVO3, and LST8, respectably 
(Jacinto, Loewith et al. 2004; Sarbassov, Ali et al. 2004).  mTORC2 associates and 
phosphorylates Akt/PKB on Ser473 within the carboxyl-terminal hydrophobic motif 
(Hresko and Mueckler 2005; Sarbassov, Guertin et al. 2005).  Function and regulation 
mechanism of mTORC2 are not clearly defined yet.   
Dictyostelium discoideum 
Dictyostelium discoideum, a soil-living amoeba, has unique advantages for studying the 
molecular mechanisms underlying cytokinasis and chemotaxis.  Pianissimo, the D. 
discoideum homolog of AVO3, encodes a cytosolic regulator of receptor- and G 
protein-mediated activation of adenylate cyclase ACA (Chen, Long et al. 1997).  The 
AVO1 homolog RIP3 (Ras-interacting protein) was also isolated as a component of the 
Ras regulatory network, that is required for signal relay and proper chemotaxis (Lee, 
Parent et al. 1999).  Unlike the counterparts in yeast, both genes in D. discoideum are 
not essential for growth.  However, disruption of each gene eliminates ACA activity in 
response to an exogenous cAMP signal, and impairs the ability for chemotaxis (Chen, 
Long et al. 1997; Lee, Parent et al. 1999).  Recently, mass spec analysis and 
co-immunoprecipitations revealed that Pianissimo and RIP3 interact with the 
Dictiosterium homolog of TOR and LST8, indicating that TORC2 is conserved in D. 
discoideum  (Lee, Comer et al. 2005; Sasaki and Firtel 2006).  Dd-LST8 disruption 
mutant is defective in ACA activation and fails in chemotaxis, similar to either pia and 
rip3 mutants (Lee, Comer et al. 2005; Sasaki and Firtel 2006).  Taken together, these 
data indicates that TORC2 in D. discoideum positively regulates ACA activity in 
response to exogenous cAMP signals, and mediates cytokinasis and chemotaxis.  
Although the finding that TORC2 might be involved in RAS-cAMP signaling pathway 
is not confirmed yet in the other organisms, remodeling actin cytoskeleton and 
maintaining polarity in Dictyostelium represent a common function of TORC2 which is 
found in other organisms.    
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Sphingolipids as a membrane component and 
signaling molecule 
Sphingolipids are essential components of cellular membranes in eukaryotic cells.  
First described by Johann L.W. Thudichum in 1884 as an enigmatic compound found in 
brain tissue (Thudichum 1884), sphingolipids are now recognized as a building block of 
the cellular membrane, a signal molecule of intracellular signal transduction, and a 
substance of several disorders.  
Sphingolipid structure 
All sphingolipids contain a ceramide which consists of a long-chain sphingoid base (in 
general, sphingosine, sphinganine, or phytosphingosine, see below) and a fatty acid 
molecule attached by an amide bond to carbon 2 in the sphingoid base. 
 
 
Figure I-2. Molecular structure of sphingolipid 
The structure of sphingolipids contains sphingoid base (shown as sphingosine in this figure) 
that is linked to a fatty acid molecule through an amide bond, thereby forming the ceramide 
unit.  Addition at the polar head group provides property of the sphingolipids.  In yeast, 
inostolphosphate, mannosyl inositolphsphate, or  mannosyl 
diinositolphophatephosphocholine to ceramide leads to inositol phosphorylceramide (IPC), 
mannosylinositol phosphorylceramide (MIPC), and mannosyldiinositol phosphorylceramide 
(M(IP)2C).  In mammal, phosphocholine or carbohydrates to ceramide, for example, leads to 
sphingomyelin or glycosphingolipids, respectively 
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The sphingoid base normally consists of 18- or 20- carbon alkyl chain, in which two 
atoms from L-serine and the others from fatty acyl CoA, however the yeast serine 
palmitoyltransferase, the first enzyme of sphingolipid biosynthesis, can use C12, and 
C14 fatty acyl CoA as a substrate as well (Pinto, Wells et al. 1992).  The sphingoid 
base often has a modification with either a hydroxyl group at position 4 or a 
trans-double bond at carbon 4 and 5 (note that sphingoid base with the trans-double 
bond is called sphingosine, whereas sphingoid base without the trans-double bond is 
called sphinganine).  The length of the fatty acid is from 14 to 30, probably providing 
some physical characterizations that enable sphingolipids to form ‘lipid rafts’.   
Sphingolipids have a polar head group which provides unique properties to the lipids.  
Distinguished by the polar head group, yeast have three major complex sphingolipids 
(Dickson and Lester 2002): inositol phosphorylceramide (IPC), mannosylinositol 
phosphorylceramide (MIPC), and mannosyldiinositol phosphorylceramide (M(IP)2C).   
In mammals sphingolipids can also be categorized by the polar head group into three 
classes; ceramide, sphingomyelin, and glycosylceramide, although there are huge 
structural variations amongst head groups (Futerman and Hannun 2004).   
 
Sphingolipid biosynthesis in yeast 
The sphingolipid biosynthesis in yeast consists of several catalytic steps in the ER and 
Golgi.  The first reaction of the synthesis, condensation of L-serine and palmitoyl-CoA, 
is known as a rate-limiting step of the reaction chain, and the final product is 
mannosyldiinositol phosphorylceramide (M(IP)2C).  
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Figure I-3. Schematic overview of the yeast sphingolipid biosynthetic pathway 
To avoid confusion, complex sphingolipids B’and D species are not illustrated here. The 
B’species are hydoxylation form of ceramide A catalyzed by SCS7. The D species are the C 
species with hydroxylated long chain fatty acid.  
3-KDS 3-ketodihydrosphingosine, PHS phytosphingosine, IPC inositol phosphorylceramide, 
MIPC mannose inositol phosphorylceramide, M(IP)2C mannose di-inositol 
phosphorylceramide PI phosphatidylinositol, DAG diacylglycerol 
 
Serine palmitoyltransferase 
The first step of sphingolipid biosynthesis in S. cerevisiae as well as mammals involves 
condensation of L-serine and palmitoyl-CoA by the serine palmitoyltransferase, a 
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rate-limiting enzyme of the de novo sphingolipid biosynthesis.  The product of this 
reaction is 3-ketodihydroshingosine (3-KDS) (Pinto, Wells et al. 1992; Nagiec, 
Baltisberger et al. 1994).  The enzymatic activity of the serine palmitoyltransferase 
depends in vitro on supply of its substrates, serine and palmitoyl-CoA, but not on its 
products either 3-KDS or sphinganines, suggesting that either feedback inhibition or 
repression of enzyme synthesis could be very mild (Pinto, Wells et al. 1992).   The 
serine palmitoyltransferase is supposed to be a heterotrimer composed of the two 
homologous units LCB1 and LCB2, and a small protein TSC3 (Gable, Slife et al. 2000).  
LCB1 and LCB2 are required for SPT activity in all eukaryotes (Hanada 2003).  
Sequence analysis reveals that both proteins have at least one potentail transmembrane 
domain at their N-terminus and an aminotransferase motif around 320 aa.  Disruption 
of either of these genes cause lethality, which can be suppressed by exogenous 
sphingoid bases (Pinto, Wells et al. 1992).  TSC3, an 80 amino acid protein, was 
identified as a component of the serine palmitoyltransferase complex that optimizes the 
serine palmitoyltransferase activity upon heat stress (Gable, Slife et al. 2000).  So far, 
TSC3 orthologues are found only in S. cerevisiae.  Disruption of TSC3 induces a heat 
sensitive phenotype, indicating that sphingolipids are required for heat stress response.  
TSC3 may bind and deliver palmitoyl-CoA to the SPT, thus increasing its activity 
(Gable, Slife et al. 2000; Monaghan, Gable et al. 2002).   
The serine palmitoyltransferase activity is inhibited by myriocin/ISP-1, initially isolated 
as an antibiotic and immunosuppressant from Myriococcum albomyces, Isaria sinclairi, 
and Mycelia sterilia (Miyake, Kozutsumi et al. 1995).  The inhibitory effect of 
myriocin on the serine palmitoyltransferase might be caused by the structure of the 
molecule which is an analogue of its product sphingosine. Consisted with this, 
myriocin-containing affinity chromatography carried out a screening of myriocin 
binding protein and isolated LCB1 and LCB2 (Chen, Lane et al. 1999).  The serine 
palmitoyltransferase localizes at the endoplasmic reticulum confirmed by GFP fusions 
with LCB1 and LCB2 (Habeler, Natter et al. 2002; Jockusch, Voigt et al. 2003; Han, 
Gable et al. 2004), therefore the reaction of the serine palmitoyltransferase would occur 
in the ER 
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3-keto reductase 
After the initial condensation of L-serine and palmitoyl-CoA into 3-KDS, 3-KDS is 
immediately reduced using NADPH by the 3-keto reductase TSC10 into sphinganine, 
also called dihydrosphingosine (DHS) (Pinto, Srinivasan et al. 1992; Beeler, Bacikova 
et al. 1998).  This reaction also occurs in the ER.  Deletion of TSC10 makes yeast 
auxotroph to sphinganine or its hydroxylation form sphingosine (Beeler, Bacikova et al. 
1998).   
Enzymes that modify sphingoid bases 
Sphinganine can be modified in three ways.  The first way is hydroxylation at the C-4 
position by SUR2, producing phytosphingosine (PHS, also called 4-hydroxyshinganine) 
(Grilley, Stock et al. 1998).  The second way is phosphorylation at C-1 position of the 
sphingosine backbone by sphingoid base kinase LCB4 and LCB5 providing 
sphinganine-1-phosphate (DHS-1P) (Nagiec, Skrzypek et al. 1998).  The third way is 
condensation with a very long chain fatty acid by ceramide synthase converting into 
sphinganine-derived ceramide (Guillas, Kirchman et al. 2001; Schorling, Vallee et al. 
2001; Vallee and Riezman 2005).   
Phytosphingosine is the primary sphingoid base in yeast (Grilley, Stock et al. 1998).  
This intermediate of sphingolipid has unique property that 20 µM of exogenous 
phytosphingosine inhibits cell growth, while structurally similar or metabolically related 
molecules including 3-KDS, sphinganine, C2-phytoceramide, and stearylamine did not 
affect cell growth (Chung, Mao et al. 2001).  Also, phytosphingosine inhibit uptake of 
uracil, tryptophan, leucine, and histidine (Chung, Mao et al. 2001).   
Phytosphingosine is a product of hydroxylation of sphinganine catalyzed by SUR2, with 
NADPH as electron donor (Grilley, Stock et al. 1998).  SUR2 is an integral membrane 
protein localizing in the ER (Habeler, Natter et al. 2002; Jockusch, Voigt et al. 2003).  
SUR2 is also able to hydroxylate sphinganine-derived ceramide into 
phytosphingosine-derived ceramide (Grilley and Takemoto 2000).  As expected, 
disruption of SUR2 induces accumulation of IPC-A and IPC-B’ (Haak, Gable et al. 
1997; Grilley, Stock et al. 1998), which are sphinganine derivate sphingolipids without 
hydroxylation at C4 position, and also did influence cellular phospholipid levels 
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(Cliften, Wang et al. 1996).  However, disruption of SUR2 does not affect cell viability.  
Together with the fact that sphinganine-derived ceramide and its derivatives are rarely 
found in the wild type strain W303 (Grilley, Stock et al. 1998), even though 
phytosphingosine is the primary sphingoid base, there is redundancy between 
phytosphingosine and sphinganine, and even between phospholipids (Cliften, Wang et 
al. 1996).  
Sphinganine-1-phosphate and phytosphingosine-1-phosphate (S1P) are bioactive lipid 
metabolites that have been implicated in many biological processes (Chalfant and 
Spiegel 2005).  One example of function of S1P is cell growth and cell death.  
Abnormal accumulation of S1P induces cell death.  Double disruption of dpl1 ysr2, 
both encode proteins in degradation of S1P, were inviable, but additional disruption of 
lcb4, responsible for about 97% of total phosphorylation activity of S1P (Nagiec, 
Skrzypek et al. 1998), can suppress the phenotype (Kim, Fyrst et al. 2000; Zhang, 
Skrzypek et al. 2001).  Furthermore, overexpression of either LCB4 or LCB5 in the 
triple mutant dpl1 ysr2 lcb4 induced growth inhibition, suggesting that S1P 
accumulation can inhibit cell growth.  LCB4 was localized to the ER whereas LCB5 
was found to co-fractionate with Golgi membranes (Funato, Lombardi et al. 2003).   
In mammals, function of S1P is much investigated than yeast.  S1P controls numerous 
aspects of cell physiology, including cell survival and mammalian inflammatory 
responses (Spiegel and Milstien 2003; Chalfant and Spiegel 2005).  Mammalian can 
sense extracellular S1P as a signal through its interaction with a family of five specific 
G-protein-coupled receptors (GPCRs), S1P1 to S1P5 (Spiegel and Milstien 2003; 
Goetzl and Rosen 2004).  Furthermore, similarly to other potent lipid mediator, S1P 
also has intracellular function independent of these receptors (Spiegel and Milstien 
2003).   
Ceramide synthase 
As mentioned above, hydroxylation of sphinganine produces phytosphingosine.  In the 
ER, phytosphingosine is further modified to ceramide by the ceramide synthase.  Two 
types of ceramide synthases are known.  One is a minor acyl-CoA-independent 
ceramide synthase encoded by YPC1 and YDC1 that are able to catalyze both synthesis 
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and breakdown of ceramide (Mao, Xu et al. 2000; Mao, Xu et al. 2000).  The other is 
the acyl-CoA-dependent ceramide synthase, that is composed of LAG1, LAC1, and 
LIP1 (Guillas, Kirchman et al. 2001; Schorling, Vallee et al. 2001; Vallee and Riezman 
2005).  LAG1 and LAC1 that share 87.3% similarity at the amino acid level are 
functionally equivalent.  A double deletion mutant of lag1 lac1 has reduced 
sphingolipid levels because of  less activity of the acyl-CoA-dependent ceramide 
synthase (Guillas, Kirchman et al. 2001; Schorling, Vallee et al. 2001).  Double 
mutation is lethal or results in very slow growth, probably due to accumulation of 
phytosphingosine and S1P (Schorling, Vallee et al. 2001).   
IPC synthase 
IPC is synthesized by a ceramide phosphoinositol transferase, also called IPC synthase.  
This synthase are encoded on AUR1 named after aureobasidin A resistance 1.   AUR1 
was identified as a gene whose mutation provides resistance for antifungal drug 
aureobasidin A (LY295337) (Heidler and Radding 1995).  It consists of 401 amino 
acids and contains a PAP2 domain, which is found in the enzyme type 2 phosphatidic 
acid phosphatases.  Subsequent studies revealed that disruption mutants of AUR1 fail 
to synthesize complex sphingolipid species and accumulates ceramide (Nagiec, Nagiec 
et al. 1997), indicating that AUR1 encodes an IPC synthase.  AUR1 localizes primarily 
in the Golgi and not in the ER (Levine, Wiggins et al. 2000).  Taken together with the 
fact that IPC localizes at the Golgi fraction and that ceramide exists in the ER fraction, 
AUR1 converts ceramide to IPC probably in the Golgi (Funato and Riezman 2001).  
Deletion of AUR1 induces microtubule disassembly and chitin delocalization, a similar 
phenotype to aureobasidin A treatment (Hashida-Okado, Ogawa et al. 1996).  The 
mechanism that causes this phenotype is unclear, but the findings suggest a connection 
between sphingolipids biogenesis and cell morphology.   
MIPC synthase 
MIPC is a mannosylated form of IPC.  SUR1, encoding MIPC synthase subunit, has 
been originally identified as the suppressor mutant of rvs161, whose phenotypes are 
reduced viability upon starvation and sensitivity to several drugs with non-related 
structure (Desfarges, Durrens et al. 1993).  Later on, the gene was independently 
isolated as CSG1, by screening for growth phenotypes in the presence of 100 mM 
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calcium (Fu, Beeler et al. 1994).  Disruption mutant of sur1/csg1 fails to accumulate 
glycogen upon stationary phase entry, and has dumbbell-like morphology in stationary 
phase (Desfarges, Durrens et al. 1993).  It was therefore speculated that SUR1 might 
play a role in maintenance of the cell membrane.  Indeed, SUR1 mutant cells show an 
overall decrease of the phospholipid amounts and modifications in the relative contents 
of some phospholipid classes (Desfarges, Durrens et al. 1993).  Consequential studies 
revealed that sur1 mutants have reduced MIPC and M(IP)2C amounts, and accumulate 
IPC species, suggesting that SUR1 is required for IPC monnosylation (Beeler, Fu et al. 
1997).  Amino acids 56 – 148 in SUR1, located between transmembrane domain I and 
II, are homologous to the catalytic domain of the OCH1 and HOC1-encoded α-1, 6- 
mannosyltransferase, supporting the idea that SUR1 is a mannosyltransferase of IPC 
(Beeler, Fu et al. 1997).  Recently, CSH1 has been identified as a mannosyltransferase 
component which has redundant functions of SUR1 (Uemura, Kihara et al. 2003; 
Lisman, Pomorski et al. 2004).  CSH1 is highly homologous to SUR1 (71% similarity 
and 65% identity) and CSH1 protein sequence displays similarity to the sequence in the 
mannosyltransferases as well as SUR1.  Single deletion mutants of either CSH1 or 
SUR1 can synthesize MIPC and M(IP)2C, however a double deletion of CSH1 and 
SUR1 completely blocks MIPC and M(IP)2C synthesis (Uemura, Kihara et al. 2003; 
Lisman, Pomorski et al. 2004), indicating that these proteins have redundant functions 
as mannosyltransferases of IPC.  A further study of SUR1 and CSH1 has demonstrated 
that these two proteins have different substrate specificity (Uemura, Kihara et al. 2003).   
The other subunit of MIPC synthase is CSG2.  CSG2 was isolated as a calcium 
sensitive mutant but not strontium sensitive, indicating that it does not have defects in 
the vacuolar transport system, which would cause both calcium and strontium 
sensitivity (Beeler, Gable et al. 1994).  CSG2 encodes a putative membrane protein 
with nine transmembrane domains.  Amino acid 95-106 within the first cytoplasmic 
loop of CSG are homologous to a consensus Ca2+-binding loop of the EF-hand.  
Although the growth rate of csg2 null mutants is similar to wild type in the absence of 
calcium, concentrations higher than 10 mM calcium decreases the growth rate of csg2 at 
26°C.  In the presence of calcium, csg2 mutant accumulate Ca2+, probably in a 
nonvacuolar organelle (Beeler, Gable et al. 1994).  Disruption mutants of csg2 fail to 
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synthesize MIPC, but since CSG2 has no homologous sequence to mannosyltransferase 
reactive site, function of CSG2 is speculated to be regulatory subunit of MIPC synthase 
(Zhao, Beeler et al. 1994; Beeler, Fu et al. 1997; Uemura, Kihara et al. 2003; Lisman, 
Pomorski et al. 2004).   Physical interaction between CSG2 and both CSH1 or SUR1 
can support this hypothesis (Uemura, Kihara et al. 2003).   
VRG4 that encodes a GDP-mannose transporter is also required for monnosylation of 
IPC, since VRG4 delivers GDP-mannose from the cytosol to lumen of the Golgi (Dean, 
Zhang et al. 1997). 
M(IP)2C synthase 
A further modification of MIPC, addition of an inositol phosphate to the head group of 
MIPC, takes place at the Golgi.  This modification that produces mannose 
di-inositolphosphotidyl ceramide [M(IP)2C] is performed by insitolphosphotransferase 1 
(IPT1).  IPT1 was identified by sequence comparison as the only putative homolog of 
the AUR1 in the S. cerevisiae genome sequence data base (Dickson, Nagiec et al. 1997).  
Mutants baring disruption of IPT1 fails to produce M(IP)2C, and accumulates its 
precursor MIPC, indicating that IPT1 is indeed the M(IP)2C synthase.  Although 
M(IP)2C is the most abundant sphingolipid found in the plasma membrane, an IPT1 
disruptant did not show any growth defect either in rich media or several stress 
conditions including heat shock (52°C), high salt stress (0.75 M NaCl), and low pH 
(pH4.1), indicating that M(IP)2C is not really necessary for responding to these stresses 
(Dickson, Nagiec et al. 1997).  Recent studies provided some interesting findings 
toward elucidation of M(IP)2C function.  Disruption of IPT1 confers tolerance to 
exogenous zymocin, a trimeric protein toxin complex which inhibits cell growth (Zink, 
Mehlgarten et al. 2005).  In contrast, overexpression of IPT1 enhances zymocin 
sensitivity.  Since exogenous zymocin has to be taken up to perform its toxicity, it is 
speculated that M(IP)2C participates in endocytosis (Zink, Mehlgarten et al. 2005).   
Sphingolipid catabolism in yeast 
As many other degradation mechanisms, study of sphingolipid catabolism in yeast is 
less focused than its anabolism.  On other hand, sphingomyelinases in mammals, 
which hydrolyze the phosphodiester linkage of sphingomyelin to produce ceramide and 
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phosphorylcholine, are well-studied because the enzyme acts as key regulators of the 
intracellular levels of ceramide (Smith and Merrill 2002) and apoptosis and cell 
differentiation and cell proliferation (Claus, Russwurm et al. 2000; Gulbins and Li 
2006).  In S. cerevisiae, at least four classes of sphingolipid degradation enzymes have 
been identified which depredate sphingolipid and its derivatives.   
 
 
 
 
Figure I-4. the yeast sphingolipid catabolism 
See text for detail.  
 
Inositol phosphosphingolipid phospholipase C 
Yeast Inositol phosphosphingolipid phospholipase ISC1 has 30% identity to neutral 
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sphingomyelinase of mammals, and shares several common features including 
hydrolytic activity, the requirement of Mg2+ for optimal activity, optimal neutral pH, 
and the conserved P-loop-like domain found in the entire family of sphingomyelinases 
(Sawai, Okamoto et al. 2000).  ISC1 can hydrolyze phosphoceramides, i.e. all complex 
sphingolipids, to generate ceramide.  Deletion strain of ISC1 is loss of sphogolipase 
activity, suggesting that ISC1 is the only shingolipase in yeast.  Regulation of ISC1 
activity in vivo is supposed to depend on mitochondrial lipid phosphatidylglycerol and 
cardiolipin (Vaena de Avalos, Okamoto et al. 2004; Vaena de Avalos, Su et al. 2005).   
Ceramidase 
Two ceramidase are identified in S. cerevisiae.  YPC1 preferentially hydrolyzes 
phytoceramide (Mao, Xu et al. 2000), whereas YDC1 hydrolyzes dihydroceramide 
preferentially and phytoceramide only slightly (Mao, Xu et al. 2000).  Deletion of YPC 
and YDP1 or both did not apparently affect growth, suggesting neither gene is essential 
(Mao, Xu et al. 2000).  However, the ydc1 deletion mutant, but not the ypc1 deletion 
mutant, is sensitive to heat stress, supporting the idea that the two enzymes have distinct 
physiological functions (Mao, Xu et al. 2000). 
Sphingoid base phosphate phosphatase 
Sphingoid base phosphate phosphatase LCB3/LBP1/YSR2 was separately identified as 
a mutant that confers resistance to sphingosine (Mandala, Thornton et al. 1998), and that 
accumulates phosphorylated sphingoid bases (Mao, Wadleigh et al. 1997).  The 
deletion of LCB3 results in the accumulation of phosphorylated sphingoid bases, 
reduced ceramide levels, and fails to incorporate exogenous dihydrosphingosine into 
sphingolipids (Mao, Wadleigh et al. 1997; Mandala, Thornton et al. 1998).  The 
homolog of LCB3, YSR3/LBP2 also encodes sphingoid base phosphate phosphatase that 
specifically dephosphorylates sphinganine 1-phosphate (Mao, Wadleigh et al. 1997).   
Sphingoid base phosphate lyase 
In addition, yeast express sphingoid base phosphate lyase encoded by DPL1, which 
cleaves the substrates to yield ethanolamine-1-phosphate and hexadecanal (Saba, Nara 
et al. 1997).  Disruption mutants of DPL1 accumulate sphingoid base phosphates (Kim, 
Fyrst et al. 2000) at slightly elevated levels (Skrzypek, Nagiec et al. 1999; Kim, Fyrst et 
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al. 2000).  This effect is further enhanced in dpl1 lcb3 double mutants with 500 times 
greater levels of sphingoid base phosphate relative to wild type (Skrzypek, Nagiec et al. 
1999; Kim, Fyrst et al. 2000).  Although the functions of sphingoid base phosphate in 
yeast are largely unknown, recent evidence suggests a role for these lipids in resistance 
to heat stress, in the shift from fermentative to respiratory growth, and in messengers of 
calcium signaling (Skrzypek, Nagiec et al. 1999; Kim, Fyrst et al. 2000; Birchwood, 
Saba et al. 2001). 
Sphingolipid function in yeast 
As a building blocks of membranes 
Sphingolipids are components of cellular membranes.  Cellular membranes are 
composed of a mixture of lipids and proteins, as suggested by the fluid mosaic model 
proposed by Singer and Nicolson back in 1972 (Singer and Nicolson 1972).  Studies 
on membranes conducted in the past 24 years draw a much more detailed picture of the 
membrane structures (Engelman 2005), revealing that membranes are typically very 
crowded with proteins, and that their bilayers vary considerably in thickness.  Together 
with phospholipids, sphingolipids form the lipid bilayers which distinguish the 
intracellular environment from the extracellular environment.  The lipid composition 
of a typical plasma membrane in S. cerevisiae contains 30% sphingolipid species and 
70% phospholipid species in weight (Patton and Lester 1991).  As both lipid species 
have similar molecular weight and mass, sphingolipids are speculated to occupy 30% of 
the lipid surface area of the cell membrane.  
It is known that sphingolipids can aggregate with themselves in cellular membranes and, 
with sterol-backbone lipids, form separate domains which are less fluid than the bulk 
phospholipids.  These sphingolipid-based microdomains, or "lipid rafts", offer active 
spots where protein-protein interactions are enhanced, and where signal transduction, 
lipid and protein trafficking, and enzymatic reactions are accelerated (Simons and 
Ikonen 1997; Edidin 2003; Munro 2003; Simons and Vaz 2004).    
As signaling molecules 
Sphingolipids are known to function as signaling molecules that regulate many cellular 
processes, including cell growth, endocytosis, and stress response.   
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Cell growth 
Sphingolipids are essential for cell growth and survival, since yeast strains defective in 
sphingolipid biosynthesis are non-viable, unless exogenous sphingoid bases are 
supplied.  Disruption of a subunit of serine palmitoyltransferase, either lcb1 or lcb2, is 
lethal (Dickson, Wells et al. 1990).  TSC10, the 3-ketosphinganine reductase 
responsible to the next reaction of serine palmitoyltransferase, is also essential for 
growth (Beeler, Bacikova et al. 1998).  Double disruption of lac1 and lag1, 
components of ceramide synthase, shows very slow growth (Barz and Walter 1999; 
Schorling, Vallee et al. 2001), and single deletion of the other component of ceramide 
synthase lip1 shows very slow growth as well as the double disruption lac1 lag1 (Vallee 
and Riezman 2005).  Consistent with the deletion mutants, inhibition of the synthase 
activity by the specific inhibitor of ceramide synthase Fumonisin A leads to a severe 
growth defect (Wu, McDonough et al. 1995), indicating ceramide are required for 
effective vegetative growth.    IPC synthase encoded by AUR1 is also an essential for 
growth, and an inhibitor of AUR1, aureobasidin A, blocks cell growth (Heidler and 
Radding 1995; Hashida-Okado, Ogawa et al. 1996; Nagiec, Nagiec et al. 1997; 
Hashida-Okado, Yasumoto et al. 1998).  While the sphingolipids mentioned above are 
required for cell growth, MIPC and M(IP)2C, the end products of the sphingolipids 
biosynthesis pathway are not essential for growth.   Inactivation of either MIPC 
synthase by csg2 deletion (Beeler, Gable et al. 1994) or M(IP)2C synthase by ipt1 
deletion did not significantly slow cell growth under good growth conditions (Dickson, 
Nagiec et al. 1997).  These findings suggest that sphingolipids are important molecules 
for cell growth, especially sphingoid bases, ceramide, and IPC, which are critical.   
How do sphingolipids contribute cell growth?  The complete explanation is still 
unknown, but the findings described above support the existence of other functions for 
sphingolipids except as building blocks of cellular membranes.  Another function of 
sphingolipids is as signaling molecules, which response to environmental changes.   
One crucial study with the serine palmitoyltransferase inhibitor myriocin/ISP-1 has 
given a clue.  Myriocin inhibits serine palmitoyltransferase activity, thereby blocking 
cell growth.  A multi-copy suppressor screening with the drug identified YPK1, a gene 
encoding a serine/threonine kinase (Sun, Taniguchi et al. 2000).  A functional homolog 
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of YPK1 is a mammalian protein kinase SGK, which is phosphorylated by PDK1, a 
downstream kinase of phosphatidylinositol 3-kinase (PI3K), suggesting that 
sphingolipids participate in a signal transduction pathway.   
In mammalian cells, the PDK1-PKB signaling cascade downstream of PI3K mediates 
the physiological effects of insulin and other growth factors.  PDK1 can phosphorylate 
a conserved residue within the activation loop of the AGC subfamily of protein kinases, 
containing PKB, PKC isozymes, p70 S6 kinase, and SGK (Vanhaesebroeck and Alessi 
2000; Biondi 2004; Long, Muller et al. 2004; Mora, Komander et al. 2004).  Together 
with PKB, SGK mediates the readouts of PI3K signaling, such as cell survival and cell 
cycle progression (Vanhaesebroeck and Alessi 2000; Mora, Komander et al. 2004).   
Kinase dead mutants of YPK1 fail to suppress the growth defect upon myriocin 
treatment, suggesting that the kinase activity of the YPK1 is essential for the 
suppression (Sun, Taniguchi et al. 2000).  YPK1 is a phospho-protein and the 
phosphorylation of YPK1 is decreased upon myriocin-induced sphingolipid depletion.  
Addition of exogenous sphinganine to myriocin-treated cells suppresses the reduction in 
the phosphorylation of YPK1, indicating that intercellular sphingolipids mediates the 
phosphorylation of YPK1 (Sun, Taniguchi et al. 2000).   
Which protein(s) can phosphorylate YPK1?  It has been shown previously that PKH1 
can phosphorylate Thr504 in YPK1 (Casamayor, Torrance et al. 1999).  PKH1 and its 
homolog PKH2 encode protein kinases with catalytic domains closely related to those 
of human and Drosophila PDK1 (Casamayor, Torrance et al. 1999).  Similar to YPK1, 
overexpression of PKH1 suppresses the myriocin-induced cell growth defect (Sun, 
Taniguchi et al. 2000), suggesting that sphingolipids can act as a signaling molecules 
and  upregulate YPK1 kinase activity via PKH.  Indeed, nanomolar concentrations of 
sphingoid base increase PKH1 and PKH2 kinase activity in vitro (Friant, Lombardi et al. 
2001), indicating that PKH could be a link between the lipid molecules and a signaling 
cascade consisted by kinases.  PKH1 and PKH2 also phosphorylate PKC1 in vitro 
(Friant, Lombardi et al. 2001).  PKC1 in yeast, the only yeast homolog of the 
mammalian protein kinase C (Levin, Fields et al. 1990), regulates MPK1-MAP kinase 
cascade and mediates the cell wall synthesis and actin cytoskeleton organization.   In 
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summary, sphingoid base, one of the intermediate of sphingolipids metabolites, plays a 
key role as a signaling molecule which activate PKH kinases and its substrates YPKs 
and PKC1 (Casamayor, Torrance et al. 1999; Friant, Lombardi et al. 2001; Schmelzle, 
Helliwell et al. 2002).   
Endocytosis 
The initial observation that sphingolipids mediate endocytosis came up with a genetic 
screening for endocytosis mutants (Munn and Riezman 1994); one of those mutants was 
allelic to the LCB1 (Sutterlin, Doering et al. 1997).  The endocytic defect of the lcb1 
mutant, named lcb1-100, could be overcome by exogenous sphingoid base (Zanolari, 
Friant et al. 2000).  Even when endogenous sphingolipid synthesis was inhibited, and 
exogenous sphingolipid could not be given a further modification, sphingoid bases were 
able to suppress the endocytic defect (Zanolari, Friant et al. 2000).  These results 
suggest that sphingoid base is required for the internalization step of endocytosis.  
Consistent with the study that showed that sphingoid base can activate PKH1 and PKH2, 
overexpression of either PKH1 or PKH2 can suppress the lcb1-100 endocytic defect 
(both fluid phase and receptor mediated internalization) and temperature sensitivity 
(Friant, Lombardi et al. 2001; deHart, Schnell et al. 2002).  In addition, a temperature 
sensitive mutant pkh-ts, harboring a chromosomal deletion of PKH2 (pkh2::LEU2) and 
a temperature-sensitive pkh1-ts mutant allele, pkh1D398G (Inagaki, Schmelzle et al. 1999), 
failed in fluid phase and receptor mediated internalization at non-permissive 
temperature 37°C (Friant, Lombardi et al. 2001).  Not only PKH kinases, but also 
YPK1 and YPK2 were found to be required for endocytosis (deHart, Schnell et al. 
2002).  These findings suggest that sphingoid bases mediate endocytosis via the 
protein kinases PKH1 and PKH2. 
Since endocytosis is tightly coupled with actin assembly (Engqvist-Goldstein and 
Drubin 2003), it is conceivable that sphingolipids mediate actin cytoskeleton 
organization.  Indeed, the serine palmitoyltransferase temperature sensitive mutant 
lcb1-100 showed actin depolarization at non-permissive temperature.  This actin defect 
was suppressed by additional sphingoid bases (Zanolari, Friant et al. 2000) and by 
overexpression of either PKH1, PKH2, YCK2 or PKC1 (Friant, Zanolari et al. 2000; 
Friant, Lombardi et al. 2001).  Thus, sphingoid bases and PKH-PKC signaling cascade 
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seems to be required for proper actin organization, but it is not clear yet how the 
cascade regulates actin organization.  Notably, PKC1 and its downstream MPK-MAPK 
signaling pathway are involved in actin regulation (Delley and Hall 1999; Levin 2005), 
so it is suspected that the signaling cascade at least partially participates in the 
regulation mechanism of actin cytoskeleton by sphingolipids.   
Stress response 
Sphingolipids are also required for stress response.  Studies of serine 
palmitoyltransferase mutant strains (lcb1-100 and 7R4), which lack newly synthesized 
sphingolipids at non-permissive temperature, have demonstrated that these lipids play a 
role in resisting heat, osmotic, and low pH stresses (Patton and Lester 1991) since the 
mutants are hypersensitive to these stresses.  Following studies on a wild type strain 
showed, upon heat stress, a transient (up to 20 min) increase in the concentration of 
phytosphingosine and sphinganinel, and a more stable increase in ceramide This 
accumulation was not observed in the mutants (Dickson, Nagiec et al. 1997).  
Treatment of sphinganine at the permissive temperature 25°C induced expression of 
STRE (stress response element) regulated genes, which are also induced by heat stress, 
suggesting that sphingolipids mediate heat stress response (Dickson, Nagiec et al. 1997; 
Cowart, Okamoto et al. 2003).  Increase of ceramide upon heat stress was inhibited by 
either australigungin or Fumonisin B1, both are ceramide synthase inhibitors, indicating 
that accumulation of sphingolipid intermediates (sphinganine, phytosphingosine, and 
ceramide) by heat stress probably results in de novo synthesis (Jenkins, Richards et al. 
1997; Wells, Dickson et al. 1998).  The transient change in these intermediates is 
consistent with the idea that these intermediates act as signaling molecules.  
Interestingly, mutants lacking increased de novo sphingolipids upon heat stress were 
found to lack the transient heat stress induced G0/G1 arrest (Shin, Matsumoto et al. 
1987; Jenkins and Hannun 2001), suggesting that newly synthesized sphingolipid 
metabolites also mediate the cell cycle arrest.   
The mechanism by which sphingolipids contribute to heat stress response is gradually 
beginning to be understood.    Upon heat stress, in the lcb1-100 strain, there was no 
induction of the major heat shock proteins (Friant, Meier et al. 2003), although 
transcription and nuclear export of mRNA of heat shock protein was not affected.  
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Translation initiation was strongly down-regulated, as demonstrated by pulse-chaise 
experiment and polysome profiling (Meier, Deloche et al. 2005).  The defects in 
translation initiation in the mutant were not observed in a ceramide synthase mutant 
(lac1 lag1ts) or a sphingoid bases kinase mutant (lcb4 lcb5), suggesting that sphingoid 
bases have a role in heat stress response (Meier, Deloche et al. 2005).  Disruption of 
the yeast eIF4E-binding protein EAP1 restored translation initiation and synthesis of 
heat shock proteins, suggesting that sphingoid bases during heat stress regulate 
translation initiation at a cap dependent step.  In addition, the PKH-YPK signaling 
cascade, a downstream target of sphingoid bases, is partially required for the stability of 
eIF4G (Meier, Deloche et al. 2005).  Taken together, the results of the studies presnetd 
above suggest that sphingoid bases are required for heat stress response, probably 
because the lipids promote translation of heat shock proteins via PKH-YPK signaling 
cascade and a cap dependent translation initiation step.  It would be interesting to 
sturdy that, for example, how PKH signaling reaches EAP1, or the contribution of the 
other signaling pathway on regulation of the translation initiation upon heat stress 
response.   
Not only de novo biogenesis of sphingolipids, ceramide and sphingoid bases can be 
generated by degradation of complex sphingolipid (hydrolysis pathway).  So far, 
contribution of the hydrolysis pathway to the heat shock response seems less impact 
than that of de novo pathway.  ISC1 hydrolyzes complex sphingolipids to ceramide.  
At 39°C for 1 h, disruption mutant of isc1 showed cell cycle arrest like wild type 
suggesting that ceramide produced by ISC1 is not likely to contribute cell cycle 
regulation in response to heat stress (Cowart, Okamoto et al. 2006).  However, the 
mutant showed decrease of the C24-, C24:1- and C26-dihydroceramide species (Cowart, 
Okamoto et al. 2006), suggesting that possibly sphingolipid hydrolysis pathway 
participates in heat shock response at different level of that of de novo sphingolipid 
biogenesis. 
As substances of several disorders 
One obvious reason that sphingolipids draw attention is that the lipids are involved in 
several human disorders, including acid sphingomyelinase deficiency types A and B, 
and Krabbe diseases.   
 37
The acid sphingomyelinase deficienies types A and B, also called Niemann-Pick disease, 
are an autosomal recessive disorders due to mutation of the sphingomyelinase gene 
(Vanier 2002).   
Krabbe disease (or globoid cell leukodystrophy ) is an autosomal recessive disorder 
resulting from the deficiency of galactocerebrosidase (Wenger, Victoria et al. 1999).  
The galactocerebrosidase is a lysosomal β-galactosidase responsible for the hydrolysis 
of several galactolipids, including galactosylceramide and psychosine 
(galactosylsphingosine).  Deficiency of the enzyme induces accumulation of its 
substrates, and accumulation of psychosine may be the cause of the pathology and 
symptoms observed in this disease (Kobayashi, Shinoda et al. 1987; Wenger, Victoria et 
al. 1999). 
Not only the two disorders written above, but also Tay-Sachs disease, Farber Disease, 
and Gaucher disease are known as autosomal recessive disorders caused by deficiency 
of enzymes in sphingolipid metabolism.  These genetic disorders confirm the 
importance of sphingolipids and the existence of regulation mechanisms of sphingolipid 
metabolism.   
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Aim of This Thesis 
The TOR signaling pathway, conserved from yeast to mammals, is essential for cell 
growth.   
The aim of this thesis is to find and describe additional functions of TOR in the model 
organism Saccharomyces cerevisiae, and to gain further understanding of how TOR 
contributes to cell growth.  We specifically focus on the TOR complex 2 signaling 
branch, and study a novel readout, sphingolipid biosynthesis.   
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PART II 
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Results 
II-1.  Analysis of AVO3 function in TOR complex 2 
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SUMMARY 
The atypical and highly conserved protein kinase TOR is a central controller of growth.  
In yeast, TOR2 is found in two functionally and structurally distinct complexes, TORC1 
and TORC2.  TORC2 contains TOR2, AVO1, AVO2, AVO3, BIT61 and LST8.  Here 
we describe a molecular analysis of the TORC2 subunit AVO3.  AVO3 has six distinct 
regions that are highly conserved from yeast to human.  AVO3 and, in particular, five 
of its conserved regions are required for the TORC2 function of signaling via the cell 
integrity pathway and polarization of the actin cytoskeleton.   AVO3 also interacts 
with the novel TORC2 component BIT2.   Our results suggest that AVO3 performs a 
positive role in TORC2 to support growth and actin organization.        
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INTRODUCTION 
TOR, the target of rapamycin, plays a crucial role in the regulation of cell growth by 
coupling the accumulation of mass to nutrient and other environmental cues (Barbet, 
Schneider et al. 1996; Schmelzle and Hall 2000; Rohde, Heitman et al. 2001; Jacinto 
and Hall 2003; Hay and Sonenberg 2004).   TOR was originally defined in 
Saccharomyces cerevisiae with the identification of mutations that confer resistance to 
the anti-fungal, immunosuppressant and anti-cancer drug rapamycin (Heitman, Movva 
et al. 1991).   TOR proteins are functionally and structurally conserved in all 
eukaryotes and are the founding members of the phosphatidylinositol kinase-related 
protein kinase (PIKK) family.  These proteins contain several known or putative 
protein-protein interaction domains, and most function as components of multiprotein 
complexes (Bakkenist and Kastan 2004).   
In budding yeast, there are two TOR genes, TOR1 and TOR2, and the TOR proteins 
function in two distinct complexes, TOR complex 1 (TORC1) and TOR complex 2 
(TORC2) (Loewith, Jacinto et al. 2002; Chen and Kaiser 2003; Wedaman, Reinke et al. 
2003; Reinke, Anderson et al. 2004).  TORC1 is composed of KOG1, TCO89, LST8 
and either TOR1 or TOR2.  When growth conditions are favorable, TORC1 promotes 
mass accumulation by stimulating ribosome biogenesis, translation initiation and 
nutrient uptake, and by inhibiting autophagy (Noda and Ohsumi 1998; Crespo, Powers 
et al. 2002).  TORC2 contains AVO1, AVO2, AVO3/TSC11, BIT61, LST8 and TOR2, 
but not TOR1.  Although AVO3 was originally named TSC11 (temperature sensitive 
suppressor of csg2) (Beeler, Bacikova et al. 1998), we prefer to use the name AVO3 to 
avoid confusion with mammalian TSC (tuberous sclerosis complex) proteins that 
negatively regulate mTOR activity (Jacinto and Hall 2003).  While TORC1 mediates 
temporal control of cell growth, TORC2 regulates the cell-cycle dependent polarization 
of actin cytoskeleton and thus controls spatial aspects of cell growth.   
Loss of TORC2 function leads to a depolarization of the actin cytoskeleton – actin 
patches are evenly distributed in the mother and daughter cell (Schmidt, Kunz et al. 
1996).  This defect in cell cycle-dependent actin organization is suppressed by 
hyperactivation of the TORC2-regulated cell integrity pathway (Helliwell, Schmidt et 
al. 1998; Loewith, Jacinto et al. 2002).  TORC2 regulates this pathway via activation 
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of the guanine nucleotide exchange factor ROM2 (Schmidt, Bickle et al. 1997).  
ROM2 converts the small GTPases RHO1 and RHO2 to an active, GTP-bound state.  
GTP-bound RHO binds and activates PKC1 (Nonaka, Tanaka et al. 1995).  PKC1, in 
turn, signals to the actin cytoskeleton via a MAP kinase cascade composed of the 
MAPKKK BCK1, the MAPKKs MKK1 and MKK2, and the MAPK MPK1/SLT2 (Lee 
and Levin 1992; Irie, Takase et al. 1993; Lee, Irie et al. 1993; Helliwell, Schmidt et al. 
1998).   
Here we investigate the function of AVO3, an essential component of TORC2.  
Disruption of AVO3 mimics a TOR2 deficiency, and AVO3 defects are suppressed by 
overexpression of signaling proteins downstream of TORC2.  Thus, AVO3 functions 
positively with TOR2 to regulate the cell integrity pathway and the cell cycle-dependent 
polarization of the actin cytoskeleton.  AVO3 is conserved throughout eukaryotic 
evolution and we show that several domains that are particularly well conserved are 
essential for the function of AVO3.  Lastly, we show that the non-essential TORC2 
components AVO2, BIT61 and its homolog BIT2 perform positive roles in TORC2 
signaling. 
  
EXPERIMENTAL PROCEDURES 
Yeast strains, plasmids and media  
The complete genotypes of yeast strains used in this study are listed in Table I.  
Plasmids used in this study are listed in Table II.  Standard techniques and media were 
used (Sherman 1991; Barbet, Schneider et al. 1996).  All cultures were incubated at 
30°C unless otherwise indicated.  
Actin staining 
Cells growing logarithmically in YPD were fixed in formaldehyde (3.7%) and 
potassium phosphate buffer (100 mM [pH 6.5]) and stained with tetramethyl rhodamine 
isothiocyanate (TRITC)-phalloidin (Sigma) to visualize actin, as described previously 
(Benedetti, Raths et al. 1994).  Actin cytoskeleton organization was assessed in several 
hundred small-budded cells, as described previously (Delley and Hall 1999). 
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Spot assay 
Logarithmically growing cells were harvested and resuspended in 10 mM TRIS pH 7.4.  
The resuspended cells were diluted in a fivefold dilution series.  4 µl of each dilution 
(10x, 50x, 250x, 1250x and 6750x diluted) were spotted on an YPD plate.  Growth 
was scored after two days at 30°C.   
MPK1 phosphorylation assay 
YPD cultures of logarithmically growing cells were heat-shocked at 39°C and harvested. 
Cell extracts were prepared as described previously (Martin, Rodriguez-Pachon et al. 
2000).  Protein concentrations of extracts were determined by using Bradford Assay 
(Bio-RAD).  Samples were denatured by addition of 5X SDS-polyacrylamide gel 
electrophoresis (PAGE) sample loading buffer and heating at 96°C for 5 min.  A total 
of 25 µg of protein (for MPK1 protein detection) or 40 µg of protein (for 
phosphorylated MAPK detection) was loaded for standard SDS-PAGE (10% 
acrylamide) and Western blot analyses.  For immunodetection, a mouse anti-HA 
antibody (12CAS) and rabbit phospho-p44/42 MAP kinase (Thr202/Tyr204) antibody 
(1:1000; Cell Signaling) were used.  Secondary antibodies were horseradish 
peroxidase-conjugated anti-mouse (anti-HA) or anti-rabbit (anti-phospho MAPK) 
antibody and detection by ECL reagents (Amersham Pharmacia Biotech). 
Immunoprecipitation and Western blotting 
YPD cultures of logarithmically growing cells were harvested, and cell extracts and 
co-immunoprecipitation were prepared as described previously (Loewith, Jacinto et al. 
2002).  Western blotting and immunodetection were performed as described above for 
the MAP kinase assay.   
RESULTS 
AVO3 is essential and required for actin cytoskeleton organization 
TORC2 regulates polarization of the actin cytoskeleton, through RHO small GTPases, 
protein kinase C (PKC1) and the MPK1 MAP kinase cascade (Helliwell et al., 1998b; 
Loewith et al., 2002; Wedaman et al., 2003).  Since AVO3 is an essential protein 
(Winzeler et al., 1999) and a subunit of TORC2 (Loewith et al., 2002; Wedaman et al., 
2003), it likely plays a role in TORC2 signaling.  To investigate this possibility, we 
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examined if an avo3 mutant phenocopies a tor2 mutant.  We constructed a strain that 
expresses HA-tagged AVO3 under the control of the galactose-inducible, glucose 
repressible GAL1 promoter and assayed this strain for the ability to form colonies.  As 
expected, this strain showed a severe growth defect when cells were grown in 
glucose-containing media (data not shown).  Previous work (Helliwell et al., 1998b) 
demonstrated that the growth and actin defects of a tor2 mutant are suppressed by 
hyperactivation of the RHO-PKC1-MAP kinase cascade.  To examine whether the 
growth of AVO3-depleted cells is restored by overexpression of TOR2 or known tor2 
suppressors, we transformed plasmids carrying these genes into the GAL1p-AVO3 strain 
and spotted the cells on glucose containing, solid medium (Figure II-1-1A).  Although 
overexpression of TOR2 did not suppress the avo3 growth defect, the growth defect was 
suppressed by multicopy ROM2, RHO2, TUS1, activated-PKC1, activated-BCK1, 
activated-MKK1 and MSS4, suggesting that, like TOR2 and AVO1 (Loewith et al., 
2002), AVO3 positively regulates signaling through the RHO-PKC1-MPK1 pathway.   
We next investigated whether AVO3 is required for polarization of the actin 
cytoskeleton.  Since actin polarization is a rapid process relative to colony formation, 
we first determined the time course of AVO3 depletion in GAL1p-AVO3 cells shifted 
from galactose- to glucose-containing media.  The HA-tagged AVO3 protein decreased 
in a time dependent manner, and was undetectable by immunoblot within 12 to 16 hours 
after the shift to glucose medium (Figure II-1-1B).  Within 12-16 hours of incubation 
in glucose medium, the AVO3-depleted cells lost actin polarization (Figure II-1-1C).  
This actin defect was suppressed by AVO3 (Figure II-1-1C, middle panels), by 
overexpression of activated-PKC1 (Figure II-1-1C, bottom panels) or by the above 
multicopy suppressors of the avo3 growth defect (RHO2, TUS1, activated-BCK1, 
activated-MKK1) (data not shown).  Thus, an avo3 mutation mimics tor2 and avo1 
mutations, suggesting that AVO3 functions positively with TOR2 and AVO1 to support 
growth and polarization of the actin cytoskeleton.   
AVO3 is required for full MPK1 activation 
To confirm that AVO3 signals through the MPK1 MAPK cascade, we examined 
heat-induced activation of MPK1 in cells depleted for AVO3.  To assay MPK1 
activation, we monitored the phosphorylation state of MPK1 using a phospho-specific 
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• Figure II-1-1
AVO3 is essential and required for actin cytoskeleton organization.  (A) Multicopy of ROM2, RHO2, 
TUS1, activated-PKC1, activated-BCK1, activated-MKK1 and MSS4 restore growth in AVO3-
depleted cells.  GAL1p-AVO3 cell (RS61-4B) containing empty vector (YEplac195) or AVO3 (pRS1), 
TOR2 (pJK3-3), ROM2 (pAS30), RHO2 (pRHO2), TUS1 (pTS38), activated-PKC1
(YCp50::PKC1(R398P)), activated-BCK1 (pRS316::BCK1-20), activated-MKK1
(YCplac33::MKK1(S386P)) and MSS4 (pSH22) were incubated on either galactose- or glucose-
containing plate.  Asterisk indicates activated-proteins.  (B) HA-AVO3 abundance in GAL1p-AVO3 
cells decreased in a time dependent manner upon shift from galactose- to glucose-containing media.  
GAL1pHA-AVO3 cells (RS61-5B) were incubated in glucose-containing media for the indicated 
times.  HA-AVO3 was immunoprecipitated and detected by anti-HA antibody.  Equal amounts of 
protein extracts were used for immunoprecipitation.  (C) Actin depolarization of AVO3-depleted cells 
was suppressed by activated PKC1.  GAL1p-AVO3 cells with empty vector, pAVO3, or pPKC1*
were incubated in YPD for 16 h.  After fixing with formaldehyde, the cells were treated with 
rhodamin-phalloidin to stain actin.  Actin was visualized by fluorescence microscopy using TRITC 
filters.  Cells were visualized by Nomarski optics.
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antibody that specifically recognizes the dually phosphorylated and thereby activated 
form of MPK1.  Wild type and GAL1p-AVO3 cells were incubated at 24°C for 16 
hours in glucose-containing medium (YPglucose) to deplete AVO3 protein (in the 
GAL1p-AVO3 strain) and then shifted to 39°C to induce phosphorylation and activation 
of MPK1 (Martin et al., 2000) (Figure II-1-2).  MPK1 phosphorylation showed similar 
induction kinetics in both strains however the magnitude of MPK1 phosphorylation was 
significantly reduced in AVO3-depleted cells.  Thus, AVO3 is required for heat-shock 
induced phosphorylation of MPK1, confirming that AVO3 signals positively through the 
MPK1 MAPK pathway. 
AVO3 localizes at the cell periphery  
To gain a better understanding of AVO3 and TORC2 function, we observed the 
subcellular localization of AVO3.  Previous studies have revealed that TOR2 is mainly 
enriched in the plasma membrane fraction on sucrose density gradient (Kunz et al., 
2000), and localized at the cell periphery (Kunz et al., 2000; Wedaman et al., 2003).  
Since AVO3 physically interacts with TOR2 (Loewith et al., 2002; Wedaman et al., 
2003), we hypothesized that AVO3 localize at the cell periphery as well.  To address 
this, indirect immunofluorescence was performed to visualize AVO3.  We constructed 
a C-terminus conjugated 13Myc-tagged AVO3 (AVO3-Myc) using PCR-recombination 
method (Longtine et al., 1998).   AVO3-Myc was expressed under control of 
endogenous promoter.  AVO3-Myc was functional, since the tagged-protein 
suppressed lethality of depleted-AVO3 (data not shown).  Indirect 
immunofluorescence against the Myc epitope revealed that AVO3 localized at the cell 
periphery, and formed patch structures (Figure II-1-3).  This peripheral localization of 
AVO3 is consistent with the previous studies that demonstrate TOR2 localization (Kunz 
et al., 2000; Wedaman et al., 2003), and the patch structure of AVO3 might correspond 
to the clusters of gold particle which visualized endogenous TOR2 under electron 
microscopy (Wedaman et al., 2003).  Even in small budded cells, the AVO3 patch 
structures are distributed both in the mother cell and the bud tip, suggesting that AVO3 
localization is independent of cell cycle (Figure II-1-3).  The AVO3 peripheral 
localization was stable upon stress conditions; starvation, high temperature (37°C), 
osmostress, and 0.005% SDS.  Rapamycin and myriocin (inhibitor of serine 
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Figure II-1-2
AVO3 is required for full MPK1 activation.  After 16 h growth in glucose medum (YPD) at 24°C, 
wild type (TS99-5C) and GAL1p-AVO3 (RS97-5A) were incubated at 39°C for indicated times (0, 
30, 60, 90 and 120 min).  Phospho-MPK1 was detected with antibody against phospho-p44/42 
MAP kinase (see Experimental procedures).  For total MPK1, anti-HA antibody was used 
because MPK1 in both strains is HA-tagged.
aniti-Myc Nomarski DAPI
Wild type
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Figure II-1-3
Cells were grown in YPD to midlog phase and fixed with 3% formaldehyde.  AVO3 localizaiton was 
examined by indirect immunofluorescence on whole fixed cell.  Wild type: TB50,  AVO3-Myc: RL40-1c
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palmitoyltransferase) also did not affect on the localization of AVO3, suggesting that 
AVO3 constantly might localizes at the cell periphery. 
AVO3 has six highly conserved regions 
To obtain further insight into AVO3 function, we compared the amino acid sequences of 
AVO3 orthologs to identify conserved regions that might be particularly important for 
AVO3 function.  A global alignment program called T-coffee 
(http://www.ch.embnet.org/software/TCoffee.html) (Notredame et al., 2000) was used 
to compare putative AVO3 orthologs from six genera (Candida sp., Schizosaccaromyces 
pombe, Neurospore crassa, Dictyostelium discoideum, Drosophila melanogaster, Homo 
sapiens).  The T-coffee analysis revealed that AVO3 orthologs contain at least 6 
conserved regions (AVO3 Conserved Regions, ACR I to VI), corresponding to amino 
acids 351-480, 740-806, 870-905, 930-1050, 1145-1220 and 1340-1406 in S. cerevisiae 
AVO3 (Figure II-1-4A).  ACRII and V (Figure II-1-4B) are more highly conserved 
than ACRI, III, IV and VI.  ACRI, II, III, IV, V and VI are 51%, 66%, 47%, 41%, 66% 
and 41% similar between S. cerevisiae and human, respectively.  The alignment also 
demonstrated that yeast AVO3, compared to fly and human sequences, contains a ~150 
amino acid extension at the N-terminus and lacks a ~500 amino acid insertion between 
ACRV and VI (Jacinto et al., 2004).  Individual BLAST searches with each conserved 
region failed to reveal any significantly related peptide sequence in other proteins.  
The alignment data indicate that AVO3 is evolutionally conserved and suggest that it 
might have a unique function.  
To determine if AVO3 has defined domains, the yeast AVO3 amino acid sequence was 
also analyzed with the Conserved Domain Database (CDD) program 
(http://www.ncbi.nlm.nih.gov:80/Structure/cdd/cdd/.shtml).  This analysis revealed 
that AVO3 has two domains at the C-terminus, so-called RasGEFN and KOG3694 
domains.  The RasGEFN domain is commonly found N-terminal to the catalytic site of 
Ras guanine nucleotide exchange factors (RasGEF).  RasGEFN is thought to play a 
structural role in maintaining the RasGEF catalytic site in a precise position 
(Boriack-Sjodin et al., 1998).  The putative RasGEFN domain in S. cerevisiae AVO3, 
amino acids 990 to 1047, falls within the C-terminal half of ACRIV and is of 
questionable significance as it was not detected with the BLAST searches described 
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Figure II-1-4
AVO3 has six highly conserved regions.  (A) Schematic diagram of AVO3 conserved regions (ACR) I to VI 
are shown in grey boxes, and corresponding amino acids of ACRI-VI are 350-480, 740-806, 870-905, 930-
1050, 1145-1220 and 1340-1406, respectably.  (B) An amino acid sequence alignment of ACRII and ACRV 
in S. cerevisiae (S.cer) and H. sapiens (H.sap).  In the middle line of each alignments, identical residues are
shown in single letter code and similar residues are shown in “+”.  The numbers correspond to the amino acid 
position of each protein. 
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above nor is it found in AVO3 orthologs outside of S. cerevisiae.  KOG3694 
(eukaryotic ortholog groups 3694) has been defined solely by computational analysis 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml, KOG v1.00, (Tatusov et al., 
2003)) and is of unknown function.  KOG3694 corresponds to ACRV and is found in 
all AVO3 orthologs but not in other proteins.  KOG3694 is unrelated to the TORC1 
subunit KOG1.   
To investigate the function of each conserved region of AVO3, we performed a deletion 
analysis on S. cerevisiae AVO3.  AVO3-myc plasmids individually containing in-frame 
deletions of each ACR, the N-terminal extension, or the RasGEFN domain (Figure 
II-1-5A) were constructed.  Sequence analyses confirmed that each construct contained 
the desired deletion.  Immunoblot analyses with anti-Myc confirmed that all constructs 
except those lacking ACRIII and ACRV expressed stable, deletion variants of AVO3 
(Figure II-1- 5B).  To determine which regions are essential for AVO3 function, the 
deletion alleles were introduced into the GAL1p-AVO3 strain, and the transformants 
were assayed for growth on YPglucose agar (Figure II-1- 5A, right column).  This 
assay revealed that ACRII and ACRIV are essential for AVO3 function and a region 
spanning amino acids 221-422 containing the N-terminal part of ACRI is also essential.  
However, although ACRIV is essential, deletion of the overlapping RasGEFN domain 
did not compromise AVO3 function, indicating that the RasGEFN domain is not the 
essential part of ACRIV.  ACRVI and the N-terminus of AVO3 are not essential for 
AVO3 function.  AVO3 deletion variants lacking ACRIII and ACRV were undetectable 
suggesting that ACRIII and ACRV are required, directly or indirectly, for AVO3 stability.  
Thus, amino acids 221-422 (containing a part of ACRI), ACRII, III, IV and V, but not 
ACRVI and the N-terminal extension of S. cerevisiae AVO3 are essential for AVO3 
function.  The RasGEFN domain is not required for AVO3 function.   
Examination of the actin cytoskeleton in the above mutants revealed a direct correlation 
between inability to grow at the nonpermissive condition (glucose medium) and a defect 
in polarization of the actin cytoskeleton (data not shown).  Thus, amino acids 221-422, 
ACRII, III, IV and V are essential for the ability of AVO3 to support both cell growth 
and actin regulation.   
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(A) AVO3 deletion allele.  Deleted amino acids are indicated next to each allele.  Functional complement 
indicates whether the deletion allele can complement the growth and actin polarization defects of GAL1p-
AVO3 cells (RS61-5B).  (B) Expression of AVO3 deletion variants.  Protein expression was detected by 
immunoblot after co-immunoprecipitations of the myc-epitope fused to each AVO3 deletion variants. 
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AVO3 interacts with BIT2 in TORC2 
Powers and colleagues recently identified BIT61 (YJL058c) as a component of TORC2 
(Reinke et al., 2004).  Disruption of BIT61 confers hypersensitivity to rapamycin but 
otherwise fails to confer a phenotype under a variety of growth conditions (Reinke et al., 
2004).  The uncharacterized S. cerevisiae protein BIT2 (Binding protein of TOR2, 
YBR270c) shares 44% identity with BIT61 (Figure II-1- 6A).  The putative protein 
BIT2 derives it name from BIT61 and has yet to be shown to bind TOR2.  BIT2 or 
BIT61 homologs are found in other fungi but not in higher eukaryotes, suggesting that 
BIT2 and BIT61 perform function(s) unique to fungi.  Global yeast two-hybrid 
analyses (Ito et al., 2001; Uetz et al., 2000) indicated that both BIT2 and BIT61 interact 
with AVO3.  These two-hybrid analyses also indicated that BIT2 binds to the TORC2 
substrates SLM1 and SLM2.  These observations suggest that BIT2 is a novel 
component of TORC2.  To confirm that BIT2 is a component of TORC2, we examined 
whether BIT2 associates with TOR2 and AVO3 in vivo.  Immunoprecipitated 
myc-tagged BIT2 co-precipitated both HA-tagged TOR2 and HA-tagged AVO3 (Figure 
II-1- 6B).  Furthermore, BIT2 binds to the other TORC2 partners AVO1 and AVO2, 
also as determined by co-immunoprecipitation experiments (data not shown).  Thus, 
BIT2 is indeed a component of TORC2.   
AVO3 functions positively with BIT2, BIT61 and AVO2 in TORC2 
Like AVO2 and BIT61, BIT2 encodes a nonessential protein.  To further examine the 
role of these proteins in TOR signaling, we investigated the phenotype of mutants 
containing all possible combinations of BIT2, BIT61 and AVO2 wild type and null 
alleles.  Single and double mutants were crossed to generate all possible combinations 
of the double and triple disruptions to assay synthetic effects on cell growth.  We did 
not observe any significant growth defects when the single, double or triple disruptants 
were incubated at low temperature (15°C), high temperature (37°C or 39°C), high 
osmolarity (1 M Sorbitol), or in the presence of a salt stress (1.2 M NaCl, 0.3 M LiCl), 
or a cell wall stress (0.005% SDS) (data not shown).  However, all the above null 
mutants, with the exception of the bit61 and bit2 single mutants, exhibited a growth 
defect when combined with an AVO3 deficiency.  bit2 GAL1p-AVO3 cells and bit61 
GAL1p-AVO3 cells grew like GAL1p-AVO3 cells, but the bit2 bit61 double mutation or 
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Figure II-1-6 
BIT2 is a component of TORC2.  (A) Alignment of the amino acid sequences of BIT61 and BIT2.  The 
alignment was generated using the ClustalW and BOXSHADE.  Black boxes indicate identical residues and 
grey boxes show amino acid similarities.  (B) BIT2 associates with AVO3 and TOR2.  Lysates from wild 
type (TB50a, lane 1), cells expressing myc-tagged BIT2 (RL155-1D, lane 2), cells expressing HA-tagged 
AVO3 (RL42-1C, lane 3), cells co-expressing HA-tagged AVO3 and myc-tagged BIT2 (RL163-8A, lane 4), 
HA-tagged TOR2 (SF43-1C, lane 5) or co-expressing HA-tagged TOR2 and myc-tagged BIT2 (RL163-8A, 
lane 6) were immunoprecipitated with anti-HA antibody (top two panels), or with anti-myc antibody (bottom 
three panels).  Immunoblots were performed with anti-HA antibody (top two panels and bottom two panels), 
or with anti-myc antibody (middle panel). 
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 the avo2 single mutation exacerbated the growth defect of GAL1p-AVO3 cells grown 
on media containing raffinose as the sole carbon source where the GAP1 promoter is 
only weakly active (Figure II-1- 7A).  Furthermore bit2 bit61 avo2 GAL1p-AVO3 cells 
exhibited an even more severe growth defect compared to either bit2 bit61 
GAL1p-AVO3 or avo2 GAL1p-AVO3 cells grown on raffinose.  Introduction of an avo2 
deletion into an avo3 temperature sensitive strain further reduced the temperature 
tolerance of the strain (data now shown).  Thus, combined with the results of the above 
binding studies, BIT2, BIT61 and AVO2 function positively with AVO3 in TORC2.  
Furthermore, as suggested by the synthetic phenotype of bit2 and bit61 mutations and 
the homology of the BIT proteins, BIT2 and BIT61 may have redundant functions.  
Finally, our observations also suggest that BIT2 or BIT61 and AVO2 perform distinct 
functions in TORC2.   
To further investigate the function of these non-essential TORC2 proteins, we examined 
the actin cytoskeleton in the above mutant cells containing all possible combinations of 
BIT2, BIT61 and AVO2 wild type and null alleles and GAL1p-AVO3.  Cells grown in 
galactose medium were shifted to YPglucose and harvested after 4, 8, or 10 hours.  
Actin defects appeared earlier in the bit2 bit61 GAL1p-AVO3, avo2 GAL1p-AVO3 and 
bit2 bit61 avo2 GAL1p-AVO3 cells compared to GAL1p-AVO3 cells (Figure II-1- 7B).  
Thus, although BIT2, BIT61 and AVO2 likely perform separate functions, both of these 
functions, like that of AVO3, seem to be required for polarization of the actin 
cytoskeleton.  
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(A) AVO3, BIT2, BIT61 and AVO2 function positively in TORC2.  (A) Wild type (TB50a), GAL1p-AVO3 
(RS61-4B), avo2 GAL1p-AVO3 (RS89-25A), bit61 GAL1p-AVO3 (RS94-23A), bit2 GAL1p-AVO3 (RS93-
7D), avo2 bit61 GAL1p-AVO3 (RS91-1A), avo2 bit2 GAL1p-AVO3 (RS92-4D), bit61 bit2 GAL1p-AVO3 
(RS95-21C) and avo2 bit61 bit2 GAL1p-AVO3 (RS90-1A) were spotted onto galactose (left panel) or 
raffinose (right panel) containing plates and incubated at 30°C for 2 days (for galactose) or 4 days (for 
raffinose).  (B) Disruptants of bit61 bit2 avo2 GAL1p-AVO3 represents actin depolarization in earlier time 
point.  After several hour pre-incubation with galactose, cells were incubated with YPglucose for the 
indicated hours.  Fixing, staining and observing cells were performed as Figure 1B.  Percentage of small-
budded cells in which actin was depolarized was counted as described in the experimental procedure. 
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Discussion 
We have demonstrated that AVO3, an essential component of TORC2, acts similarly to 
TOR2 and AVO1 to positively regulate cell growth and actin cytoskeleton organization.  
TORC2 regulates actin organization via the RHO-PKC1-MAP kinase cascade (the cell 
integrity pathway), and indeed disruption of AVO3 results in reduced signaling through 
this pathway.  However, the mechanism by which TORC2 regulates this pathway 
remains unclear.  Direct substrates of this kinase complex are SLM1 and SLM2 
(Audhya, Loewith et al. 2004), but how SLM function relates to RHO function is 
unknown.   
What is the molecular function of AVO3?  AVO3 lacks a defined functional or 
catalytic domain but does have six regions that have been highly conserved among 
AVO3 orthologs.  Five of these six regions are essential for AVO3 function but the 
roles of these domains remain to be elucidated.  At least some of the conserved 
domains may be required for interaction with other TORC2 components as TORC2 is 
also conserved(Jacinto, Loewith et al. 2004; Sarbassov, Ali et al. 2004).  Conserved 
regions ACRIII and ACRV are required for stability of AVO3, but the instability of 
AVO3 deletion variants lacking these two regions may be due to an inability of the two 
mutant proteins to assemble into TORC2.  If AVO3 performs a scaffolding role, as 
suggested by multiple conserved domains, or performs a catalytic role remains to be 
determined. 
Is AVO3 a link between TORC2 signaling and sphingolipid signaling?  AVO3 was 
originally identified as tsc11, a temperature sensitive mutation that suppresses the 
calcium sensitive growth phenotype of a csg2 mutant (Beeler, Bacikova et al. 1998).  
Interestingly, this suppressor screen also identified a temperature sensitive mutation in 
TOR2/TSC14 as a suppressor of csg2 (Beeler, Bacikova et al. 1998).  CSG2 encodes a 
subunit of the inositol phosphorylceramide (IPC) mannosyltransferase (Zhao, Beeler et 
al. 1994; Uemura, Kihara et al. 2003; Lisman, Pomorski et al. 2004).  csg2 mutants 
accumulate the sphingolipid IPC-C and die in the presence of >20 mM Ca2+ (Beeler, 
Gable et al. 1994; Zhao, Beeler et al. 1994; Haak, Gable et al. 1997; Kohlwein, Eder et 
al. 2001).  Most csg2 suppressors act by reducing IPC-C levels.  However, this does 
not appear to be the mechanism by which avo3/tsc11 or tor2/tsc14 suppresses csg2 
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(unpublished data).  The sphingolipid composition of an avo3 temperature sensitive 
mutant at permissive and nonpermissive temperatures was not significantly different 
from that of a parental wild type strain (unpublished data).  This suggests that TORC2 
does not act upstream of IPC-C synthesis.  It is possible that TORC2 signals in parallel 
to or downstream of IPC-C and that hyperactivation of one or both of these pathways is 
toxic.  The yeast PDK1 homologs PKH1 and PKH2 are activated in vitro by 
sphingolipid precursors and activate PKC1 and the PKC1-effector MAPK pathway, 
which are also a downstream effectors of TORC2 (Helliwell, Schmidt et al. 1998; 
Inagaki, Schmelzle et al. 1999; Friant, Lombardi et al. 2001), supporting the notion of 
parallel signaling.  The relationship between TORC2 and sphingolipid metabolism 
remains to be defined.  It is also unclear how downregulation of TORC2 signaling 
suppresses the calcium sensitivity of a csg2 mutant.   
We have also provided evidence that BIT2 is a component of TORC2.  BIT2, its 
homolog BIT61, and AVO2 are all non-essential components of TORC2, suggesting that 
they perform peripheral roles in TORC2.  Although, simultaneous loss of BIT2, BIT61 
and AVO2 did not affect cell growth in either good nutrient conditions or under stress 
conditions, loss of BIT2 and BIT61 or AVO2 exacerbated the growth defect of an avo3 
mutant.  This suggests that BIT2, BIT61 and AVO2, have positive functions in TORC2.  
Notably, global two-hybrid analyses suggest that BIT2 and AVO2 interact with the 
homologous proteins SLM1 and SLM2 (Uetz, Giot et al. 2000; Ito, Chiba et al. 2001).  
SLM1 and SLM2 are substrates of TORC2 (Audhya, Loewith et al. 2004).  Thus it 
seems plausible that BIT2, BIT61 and AVO2 might act as adaptors to facilitate the 
association of TOR2 with some of its substrates. 
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Table I.  Strains used in this study 
 
Strain  Genotype        
TB50a   MATa leu2-3,112 ura3-52 trp1 his3 rme1 HMLa leu 
RL37-4a-Nat TB50a avo2::NatMX 
RL42-1C  TB50a AVO3-3HA::KanMX4 
RL140-2D TB50a BIT2-13Myc::KanMX4 
RL155-1D  TB50α BIT2-13Myc::KanMX4 tor2::KanMX4 / pRS3143HA-TOR2 
RL163-8A TB50α BIT2-13Myc::KanMX4 AVO3-3HA::KanMX 
RS4-2D  TB50a [KanMX4]-GAL1p-AVO3 
RS61-5B  TB50a [HIS3MX]-GAL1p-3HA-AVO3  
RS89-25A RS61α avo2::NAT 
RS90-8A  RS61a avo2::NAT bit2::KanMX bit61::KanMX 
RS91-1A  RS61α avo2::NAT bit61::KanMX 
RS92-4D RS61a avo2::NAT bit2::KanMX 
RS93-7D RS61a bit2::KanMX 
RS94-23A RS61α bit61::KanMX 
RS95-21C RS61a bit2::KanMX bit61::KanMX 
RS97-5A  TB50a [KanMX4]-GAL1p-AVO3 MPK1-3HA::KanMX 
SF43-1C  TB50a tor2::kanMX4 / pRS3143HA-TOR2 
SW70  TB50a 3HA-TOR2 
TS99-5C  TB50a MPK1-3HA::KanMX4 
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Table II.  Vectors used in this study 
 
Plasmid Description (reference)      
YEplac195 (2µm URA3) (Gietz and Sugino 1988) 
YCplac33 (CEN URA3) (Gietz and Sugino 1988) 
pRS1 express AVO3 from the AVO3 promoter (CEN URA3) - a 5.0 kb PCR 
fragment containing the AVO3 locus (-445 to +4379) was cloned into the 
SmaI and the SacI sites of YCplac33. 
pJK3-3  expresses TOR2 (2µm URA3) (Kunz, Henriquez et al. 1993) 
pAS30  expresses ROM2 (2µm URA3) (Helliwell, Schmidt et al. 1998) 
pRHO2  expresses RHO2 (2µm URA3) (Madaule, Axel et al. 1987) 
pTS38  expresses TUS1 (2µm URA3) (Schmelzle, Helliwell et al. 2002) 
YCp50::PKC1(R398P) expresses an activated allele of PKC1 (CEN URA3) (Nonaka, 
Tanaka et al. 1995) 
pRS316::BCK1-20 expresses an activated allele of BCK1 (CEN URA3) (Lee and 
Levin 1992) 
YCplac33::MKK1(S386P)  expresses a hyperactive mutation of MKK1 (CEN URA3) 
(Watanabe, Irie et al. 1995) 
pSH22   expresses MSS4 (2µm URA3) (Helliwell, Schmidt et al. 1998) 
pRS28  expresses Myc-tagged AVO3  
pRS42  expresses myc-tagged AVO3(∆1096-1430)  
pRS43  expresses myc-tagged AVO3(∆1263-1430)  
pRS44  expresses myc-tagged AVO3(∆2-220)  
pRS45  expresses myc-tagged AVO3(∆2-422)  
pRS47  expresses myc-tagged AVO3(∆738-811)  
pRS48  expresses myc-tagged AVO3(∆870-905) 
pRS49  expresses myc-tagged AVO3(∆920-1059)  
pRS50  xpresses myc-tagged AVO3(∆990-1046)  
pRS52  expresses myc-tagged AVO3(∆1053-1252)  
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Summary 
Sphingolipids and their metabolites are known as building components of cellular 
membranes, and also as signaling molecules mediating cell growth, endocytosis, actin 
regulation, and stress response.  Here we report a crosstalk between sphingolipid 
biosynthesis and the TOR signaling pathway in Saccharomyces cerevisiae.  The target 
of rapamycin (TOR) kinase is a central component of two highly conserved multiprotein 
complexes, TORC1 and TORC2.  TORC1 is sensitive to the immunosuppressive and 
anti-cancer drug rapamycin, and controls temporal aspects of cell growth through 
regulation of transcription and translation.  TORC2 is a rapamycin insensitive complex 
that mediates spatial control of cell growth via actin cytoskeleton organization.  We 
show that TORC2 temperature sensitive mutants, tor2ts and avo3-1, are synthetically 
lethal at the permissive temperature, with partial inhibition of sphingolipid biosynthesis 
by the antibiotic myriocin.  At non-permissive temperature, the TORC2 mutants show 
reduced de novo synthesis of sphingolipids.  Consistent with this, a general reduction 
of sphingolipid contents is also observed in steady state.  In contrast, rapamycin 
treatment and loss of TORC1 function do not induce a reduction in sphingolipid 
biosynthesis.  Our findings indicate that TORC2, but not TORC1, mediate sphingolipid 
biosynthesis.  
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Introduction 
Cell growth, defined as accumulation of cell mass, is a fundamental property of cells, 
together with cell division and cell death.  In response to nutrient, many processes of 
cell growth, including transcription, translation, ribosome biogenesis, autophagy, and 
actin cytoskeleton organization are regulated by the well-conserved protein kinase TOR 
(Target Of Rapamycin) (Barbet, Schneider et al. 1996; Schmelzle and Hall 2000; Rohde, 
Heitman et al. 2001; Jacinto and Hall 2003; Hay and Sonenberg 2004; Martin and Hall 
2005; Wullschleger, Loewith et al. 2006).  TOR constitutes two distinct protein 
complexes, TORC1 and TORC2 (Loewith, Jacinto et al. 2002), which are structurally 
and functionally conserved from yeast to mammals (Wullschleger, Loewith et al. 2005).  
In S. cerevisiae, TORC1, sensitive to the immunosuppressive and anti-cancer drug 
rapamycin, consists of either TOR1 or TOR2, KOG1, TCO89, and LST8 (Loewith, 
Jacinto et al. 2002; Reinke, Anderson et al. 2004).  TORC1 controls translation and 
transcription via the type 2A-related phosphatase SIT4 and its regulatory subunit TAP42 
(Di Como and Arndt 1996; Jiang and Broach 1999; Jacinto, Guo et al. 2001).  In the 
absence of nutrients, TORC1 is inactive: under these conditions, SIT4 is released from 
TAP42, and thereby becomes active.  Released SIT4 dephosphorylates and activates 
targets such as the transcription factor GLN3 and the kinase NPR1, which are involved 
in synthesizing alternative nutrient sources (Beck and Hall 1999; Jacinto, Guo et al. 
2001).  In the presence of nutrients, in addition to maintaining SIT4 in an inactive state, 
TORC1 mediates ribosome biogenesis, by switching the forkhead-like transcription 
factor FHL1 from binding its corepressor CRF1 to its coactivator IFH1.  This 
regulation mechanism is mediated by protein kinase A (PKA) and the PKA-regulated 
kinase YAK1 (Martin, Soulard et al. 2004).  In addition, TORC1 mediates autophagy 
by controlling the ATG1 kinase-dependent organization of the pre-autophagosomal 
membrane (Mizushima, Yamamoto et al. 2001; Suzuki, Kirisako et al. 2001; Kim, 
Huang et al. 2002).  TORC2, the rapamycin insensitive complex, is composed of 
TOR2, AVO1, AVO2, AVO3, BIT61, and LST8 (Loewith, Jacinto et al. 2002; Wedaman, 
Reinke et al. 2003; Fadri, Daquinag et al. 2005).  The complex mediates cell-cycle 
dependent actin cytoskeleton organization, via RHO1-PKC1 and the 
SLT2/MPK1-MAPK cascade (Schmidt, Bickle et al. 1997; Helliwell, Schmidt et al. 
1998; deHart, Schnell et al. 2003).  In addition, it has been suggested to mediate 
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endocytosis (deHart, Schnell et al. 2003).  Recent studies have identified two 
substrates of TORC2, SLM1/2 and YPK2, both are involved in actin cytoskeleton 
regulation (Audhya, Loewith et al. 2004; Fadri, Daquinag et al. 2005; Kamada, Fujioka 
et al. 2005).  SLM1 and SLM2 contains a PH domain, and act downstream of TORC2 
and the phosphatidylinositol-4-phosphate 5-kinase MSS4 (Audhya, Loewith et al. 2004; 
Fadri, Daquinag et al. 2005).  YPK2, the yeast homolog of SGK1 (serum- and 
glucocorticoid-activated kinase), is phosphorylated at the hydrophobic motif by TORC2 
(Kamada, Fujioka et al. 2005).  YPK2 is also phosphorylated at the T loop by PKH2 
(the yeast homolog of PDK1), which acts downstream of sphingolipids in yeast 
(Casamayor, Torrance et al. 1999; Inagaki, Schmelzle et al. 1999; Friant, Lombardi et al. 
2001).  It is unclear whether SLM1/2 or YPK2 signal through RHO1 or a parallel 
pathway to the actin cytoskeleton.   
Sphingolipids are serine-backbone lipids found in cellular membranes in all eukaryotes.  
Sphingolipids and their derivatives function as building components of cellular 
membranes, but also as signaling molecules that regulate many cellular processes, 
including cell growth, endocytosis, actin regulation, and stress response (Dickson and 
Lester 2002; Obeid, Okamoto et al. 2002; Jenkins 2003; Sims, Spassieva et al. 2004).  
In yeast, LCB1 and LCB2, encoding the two subunits of a serine-palmitoyl transferase 
which catalyzes the first step of sphingolipid synthesis, are essential for growth (Pinto, 
Wells et al. 1992; Nagiec, Baltisberger et al. 1994).  Other genes that encode enzymes 
involved in sphingolipid synthesis, such as the 3-ketosphinganine reductase TSC10 
(Beeler, Bacikova et al. 1998), a ceramide synthase subunits LIP1 (Vallee and Riezman 
2005), and the inositol-phosphoryl ceramide (IPC) synthase AUR1 (Heidler and 
Radding 1995) are also essential, suggesting that sphingolipid biosynthesis is required 
for cell growth.  Sphingolipid intermediates sphinganine (DHS) and phytosphingosine 
(PHS) are known to mediate endocytosis and actin cytoskeleton regulation (Dickson 
and Lester 2002; Sims, Spassieva et al. 2004), probably since both processes are tightly 
coupled (Engqvist-Goldstein and Drubin 2003).  For example, an lcb1 mutant that fails 
to uptake α-factor and Lucifer yellow (Munn and Riezman 1994), also shows actin 
depolarization (Zanolari, Friant et al. 2000; Schmelzle, Helliwell et al. 2002).  The 
endocytic defect and actin disorganization of the lcb1 mutant can be overcome by 
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supplementing the growth media with either DHS or PHS (Zanolari, Friant et al. 2000), 
or by overexpression of PKH1, PKH2, YPK1, and YPK2, which act downstream of DHS 
and PHS (Friant, Lombardi et al. 2001; deHart, Schnell et al. 2002).  PHS and PKH 
kinases are also involved in translation initiation upon heat stress, and are required for 
the recovery from heat shock (Meier, Deloche et al. 2005).   
Interestingly, many TOR functions overlap sphingolipids functions.  As described 
above, cell growth, actin cytoskeleton regulation and endocytosis are mediated by both 
TOR signaling and sphingolipids biosynthesis.  Furthermore, some genetic links 
between the two pathways have been described (Beeler, Bacikova et al. 1998; Helliwell, 
Howald et al. 1998).  A TORC2 temperature sensitive mutant (tor2ts) can be 
suppressed by overexpression of SUR1, a gene encodeing a subunit of mannosyl 
inositolphosphoryl ceramide (MIPC) synthase (Helliwell, Howald et al. 1998).  
Reciprocally, tor2ts and AVO3 temperature sensitive mutant, avo3-1, can suppress the 
calcium sensitivity of a disruption mutant of CSG2, another subunit MIPC synthase.  
Although these suppression mechanisms are not clear, the findings suggest a 
crosstalk(s) between TORC2 signaling and the sphingolipid biosynthetic process.   
Here, we describe that TORC2 mediates sphingolipid biogenesis in S. cerevisiae.  
TORC2 deficient cells showed synthetic lethality upon treatment with myriocin, a 
specific inhibitor of the serine-palmitoyl transferase.  In addition, TORC2, but not 
TORC1 deficient cells showed less accumulation of complex sphingolipids and 
ceramide, indicating that sphingolipid biosynthesis is mediated specifically by TORC2.  
Our findings provide a novel target of TORC2 signaling pathway.   
Results 
TORC2 deficient cells are sensitive to myriocin 
The initial observation that indicated a crosstalk(s) between TORC2 signaling module 
and sphingolipid biosynthesis was a genetic interaction: overexpression of SUR1, a 
subunit of MIPC synthase could suppress lethality of tor2ts mutant (Helliwell et al., 
1998a).  Further genetic evidence came from the identification of mutants of TORC2 
components, tor2ts and avo3-1, as suppressors of calcium sensitivity, which was induced 
by disruption of CSG2, another subunit of MIPC synthase (Beeler et al., 1998).  Taken 
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together with the functional overlaps between the two pathways (see introduction), 
these evidence support the existence of a crosstalk between TORC2 and sphingolipids.  
To confirm this hypothesis, we investigated the cell viability of TORC2 deficient cells 
upon myriocin treatment.  Since myriocin is a specific inhibitor of serine 
palmitoyltransferase, which catalyses the first step of sphingolipid biosynthesis (Sun et 
al., 2000), then if both pathways are cooperating, myriocin treatment could give a 
synthetic effect on cell growth for TORC2 deficient cells.  TORC2 deficient cells, both 
tor2ts and avo3-1, did not grow upon 100 ng/ml myriocin treatment at permissive 
temperature 34°C, whereas the wild type strain formed colonies (Figure II-2- 1A).   
Colony formation of TORC2 deficient cells was defective both in a myriocin 
concentration-dependent and in a temperature-dependent manner (data not shown), 
suggesting that TORC2 and sphingolipid biogenesis are indeed cooperating to control 
growth.   
TORC2 components, AVO2, BIT61, and BIT2 contribute to myriocin tolerance 
The non-essential proteins AVO2, BIT61, and BIT2 (YBR270c) were isolated as 
interacting proteins of TOR2 in two-hybrid screens (Ito et al., 2001; Uetz et al., 2000), 
and in co-immunoprecipitations (Fadri et al., 2005; Loewith et al., 2002; Reinke et al., 
2004).  BIT61 and BIT2 are highly related proteins, sharing 45% amino acid identity 
and 61% similarity.  Although no growth defects were observed under rich medium 
conditions neither for the single deletion mutant of avo2, bit61, or bit2, nor for the avo2 
bit61 double mutant (Reinke et al., 2004), the double mutant showed a modest growth 
defect when treated with 1.0 ng/ml rapamycin (Reinke et al., 2004), and promotion of 
cytosolic localization of SLM1 (Fadri et al., 2005).  These findings suggest that the 
non-essential TORC2 components participate in TORC2 function under certain 
conditions, even though their contribution seems not to be indispensable.   
To determine whether AVO2, BIT61, and BIT2 are required for the cooperation of 
TORC2 and sphingolipids, we tested the myriocin tolerance of deletion mutants in all 
possible combinations of these three genes.  Although all single and double deletion 
mutants did not show significant growth defect at 34°C with 100 ng/ml myriocin (under 
which avo3-1 showed a growth defect), the avo2 bit61 bit2 triple mutant failed to grow 
(Figure II-2- 1B).  The growth defect of the triple mutant was more severe with higher 
Wild type
avo3-1
avo2 bit61
avo2 bit2
bit61 bit2
avo2 bit61 bit2
Wild type
tor2ts
avo3-1
 Vehicle  100 µg/ml myriocin 
 Vehicle  100 µg/ml myriocin 
A
B
68
Figures II-2-1
TORC2 deficient cells are sensitive to myriocin.  (A) Saturated cultures of wild type, tor2ts, or avo3-1 cells 
were serially diluted and spotted onto YPD plus methanol (vehicle), or YPD plus 100 µg/ml myriocin, and 
grown for two days at 34°C.  (B) Saturated cultures of wild type, avo3-1, avo2 bit61, avo2 bit2, bit61 bit2, 
and avo2 bit61 bit2 cells were serially diluted and spotted onto YPD plus methanol (vehicle), or YPD plus 
100 µg/ml myriocin, and grown for three days at 30°C. 
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myriocin doses (data not shown).  avo2 bit61 and avo2 bit2 double mutants, but not 
bit61 bit2, showed growth defects at 24°C when treated with 250 ng/ml myriocin (data 
not shown).  The synthetic growth defect of avo2 bit61 bit2 and myriocin suggests that 
these TORC2 components could be required for the cooperation between TORC2 and 
sphingolipids.   
AVO3 domains are required for the cooperation with sphingolipid biogenesis 
AVO3, an essential TORC2 component (Loewith et al., 2002; Wedaman et al., 2003; 
Wullschleger et al., 2005), has several conserved domains identified by sequence 
alignments of AVO3 orthologs from Saccharomyces cerevisiae, Dictyostelium 
discoideum, Drosophila melanogaster and Mus musculus (Jacinto et al., 2004) and from 
six fungi (Ho et al., 2005).  To determine whether these domains are required for the 
cooperation between TORC2 and sphingolipids, we examined the effect of myriocin 
treatment on domain-specific deletion mutants of AVO3.  Following the Jacinto paper 
(Jacinto et al., 2004), the six conserved domains of yeast AVO3 were chosen for 
disruption (Figure II-2- 2A).  AVO3 lacking domains I, II, III, IV or V failed to 
suppress the avo3-1 temperature sensitivity at the non-permissive temperature (Figure 
II-2- 2B), suggesting that these domains are critical for the function of AVO3.   The 
disruption mutant of domain VI, however, was able to rescue avo3-1 growth at 
non-permissive temperature.  Furthermore, disruption of domain VI, but not of the 
other domains, was able to suppress the avo3-1 growth defect upon myriocin treatment, 
similar to full length AVO3.  The domain VI deletion mutant was also able to suppress 
the actin depolarization phenotypes of avo3-1 (data not shown).  Domain VI locates 
very close to the stop codon (1340-1410 aa of 1430 aa), and the similarity of the domain 
between S. cerevisiae and H. sapience is 40%, but despite this high similarity, the 
domain is not likely to be essential for AVO3 function.  Taken together, these findings 
suggest that the conserved domains I - V of AVO3 are required for its function, and in 
particular for the cooperation with sphingolipid biogenesis to control cell growth.   
TORC2 deficient cells show less accumulation of sphingolipids 
The synthetic growth defect described above has led us to further investigate the 
cooperation between TORC2 signaling and sphingolipid biogenesis.  Since the genetic 
interaction between TORC2 and MIPC synthase indicates a modulation of synthesis of 
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Figure II-2-2
Functional analysis of AVO3 conserved regions.  (A) Schematic diagram of AVO3 conserved regions.  The 
conserved regions I to VI are shown in grey boxes, the corresponding amino acids are 350-480, 740-806, 
870-905, 930-1050, 1145-1220 and 1340-1406, respectively.  (B) Saturated cultures of avo3-1 cells carrying 
the indicated plasmid were serially diluted, spotted onto YPD plus methanol (vehicle) or 100 µg/ml myriocin, 
and grown at the conditions indicated.  .
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the complex sphingolipids inositol phosphorylceramide (IPC), MIPC, and mannosyl 
diinositolphosphoryl ceramide (M(IP)2C) (Beeler et al., 1998; Helliwell et al., 1998a), 
we hypothesized that the level of complex sphingolipids would be influenced under 
TORC2 deficiency.  To address this hypothesis, newly-synthesized complex 
sphingolipids in TORC2 deficient cells were measured using tritium-labeled inositol, 
since at least one inositol is contained in each of the complex sphingolipids.  The wild 
type and TORC2 deficient cells tor2ts and avo3-1 were incubated at the non-permissive 
temperature (37°C) for six hours to decrease TORC2 activity (Ho et al., 2005; Schmidt 
et al., 1996).  At this time point, both tor2ts and avo3-1 cells stopped growing and 
showed actin depolarization, but were still able to form colonies (data not shown).  
After two hours of labeling with [3H]-inositol at the non-permissive temperature, lipids 
were extracted.  Same amount of labeled material was loaded onto a thin layer 
chromatography (TLC), separated, and visualized on X-ray films.  After the six hour 
incubation at the non-permissive temperature, IPC levels in avo3-1 were reduced 
whereas the level in wild type was constant (Figure II-2- 3).  Consistent with this 
reduction, the levels of MIPC and M(IP)2C, the products of IPC modification, were also 
decreased in comparison with the wild type levels.  Notably, phosphatidylinositol (PI) 
level did not significantly change during the incubation, suggesting that PI can be able 
to be synthesized even though TORC2 is inactive.  Another TORC2 deficient mutant, 
tor2ts also showed a similar reduction in complex sphingolipids under the same 
experimental conditions, although this reduction was lower than avo3-1 (data not 
shown), perhaps due to the different mutant alleles.  For further confirmation, the lipid 
profile of the TORC2 deficient cells in steady-state was analyzed using mass 
spectrometry-based lipid profiling (Figure II-2- 4).  Consistent with the reduction in 
newly-synthesized complex sphingolipids on the TLC plate, IPC levels in steady-state 
in the TORC2 deficient cells were decreased (Figure II-2- 4).  In contrast, MIPC were 
slightly elevated, though there was a species-dependent response.  Another major 
difference in the lipid levels of TORC2 deficient cells besides the sphingolipid 
reduction was lyso-PI accumulation (Figure II-2- 3), and this accumulation was also 
observed in the steady state lipid profile (Figure II-2- 4).  Interestingly, the lipid 
profiling demonstrated reduction of phosphatidylserine levels in the TORC2 deficient 
mutants.  Taken together, our results indicate that TORC2 activity is required for 
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Figure II-2-3
Complex sphingolipid levels decrease in TORC2 deficient cells.  Wild type and avo3-1 cells were incubated 
for the indicated times at non-permissive temperature, and then labelled with [3H]-inositol for two hours, also 
at non-permissive temperature.  Lipids were extracted and separated by TLC with chloroform, methanol, and 
0.25% potassium chloride (55/45/10, v/v/v), and then visualized by autoradiography.  PI: 
phosphatidylinositol, IPC: Inositol phosphorylceramide, MIPC: mannosyl inositolphosphoryl ceramide, 
M(IP)2C: mannosyl diinositolphosphoryl ceramide
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Figure II-2-4
Steady state levels of IPC and phosphatidylserine in TORC2 deficient cells are decreased.  Analysis of 
phospholipids and complex sphingolipid levels in avo3-1, tor2ts and torc1ts relative to a wild type strain was 
performed using the mass spectrometry-based lipid profiling.  Levels of lipid were quantified using relevant 
internal standards and calculated relative to the wild type strain for the individual molecular species.  LPI: 
lyso-phosphatidylinositol, LPS; lyso-phosphatidylserine, PS: phosphatidylserine, PC: phosphatidylcholine, 
the other abbreviations are in figure 3. 
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 sphingolipid synthesis.   
TORC1 does not participate in the sphingolipid biogenesis 
TORC1, a distinct protein complex from TORC2, regulates cell growth in response to 
nutrients in eukaryotes.  Yeast TORC1 regulates starvation-specific transcription and 
translation via a phosphatase switch composed of the type 2A-related phosphatase SIT4, 
TAP42, and TIP41 (Cherkasova and Hinnebusch, 2003; Di Como and Arndt, 1996; 
Jacinto et al., 2001; Jiang and Broach, 1999), and ribosomal protein gene transcription 
by control of the subcellular localization of a corepressor CRF1 via protein kinase A 
(PKA) and the PKA-regulated kinase YAK1 (Martin et al., 2004).  Does TORC1 
participate in sphingolipid biosynthesis like TORC2?    To answer this question, we 
investigated whether TORC1 inactivation would cause a decrease in sphingolipid 
biogenesis.  TORC1 inactivation was performed in two ways; rapamycin treatment of 
wild type cells, and incubation at non-permissive temperature of a TORC1 temperature 
sensitive strain (torc1ts).   
Rapamycin, known as an anti-fungal, anti-tumor and immunosuppressive drug, is a 
specific inhibitor of TORC1 (Loewith et al., 2002).  Wild type strain was incubated at 
24°C for one hour with rapamycin, and then cells were labeled with [3H]-inositol for 
two hours.  Lipids were extracted and separated by TLC.  One hour treatment of 
rapamycin inhibited TORC1 activity (Loewith et al., 2002; Martin et al., 2004), but did 
not affect complex sphingolipid biosynthesis (Figure II-2- 5), suggesting that TORC1 
does not mediate complex sphingolipid biosynthesis.   
The torc1ts strain is defective in both TOR1 and TOR2 genes, but contains a plasmid 
encoding for a tor2 mutant that can carry out the TORC2 unique function, but not the 
TORC1 shared function (Helliwell et al., 1998a).  Therefore, at non-permissive 
temperature, the torc1ts cells are inactivated only for TORC1 signaling but not TORC2.  
Under the conditions where TORC2 deficiency arises (six hours at 37°C), the torc1ts 
cells were large and rounded, indicating the torc1ts are indeed defective in TORC1 
function (data not shown) (Helliwell et al., 1998a).  Lipid profiling analysis of the 
torc1ts cells, as measured by mass spectrometry, demonstrated that complex 
sphingolipids were not reduced at the non-permissive temperature (Figure II-2- 4), 
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Figure ii-2-5
Rapamycin does not affect sphingolipid synthesis.  Wild type strain at the mid-log phase was incubated with 
200 ng/ml rapamycin for 30 min, and then labelled with [3H]-inositol for two hours in the presence of 
rapamycin.  Lipids were extracted and subjected to alkaline hydrolysis with 0.6 M NaOH for 150 min at 
30°C.  Then, lipids were separated by TLC with chloroform, methanol, and 4.2 M ammonium hydroxide 
(9/7/2, v/v/v), and visualized by autoradiography.  For the abbreviations of lipids, see Figure 3.
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suggesting that inactivation of TORC1 does not influence sphingolipid biosynthesis.  
Importantly, this finding excludes a non specific effect of the long term heat stress on 
sphingolipid biosynthesis in temperature sensitive strains, since the long time heat stress 
on torc1ts did not lead to a general reduction in sphingolipid biosynthesis.  Thus, only 
TORC2, but not TORC1 or heat stress, mediates sphingolipid biosynthesis.  
TORC2 deficient cells show a decrease in sphingoid bases and ceramide.  
How does TORC2 mediate complex sphingolipid biosynthesis?  One possibility is that 
TORC2 mediates synthesis of sphingolipid intermediates, thereby influencing complex 
sphingolipid biosynthesis (Figure II-2- 6A).  Sphingolipid biosynthesis in yeast begins 
with condensation of L-serine and palmitoyl-CoA by serine palmitoyltransferase, which 
consists of three subunits in yeast, LCB1, LCB2, and TSC3 (Gable et al., 2000; Pinto et 
al., 1992b), and two subunits in mammals, LCB1 and LCB2 (Hanada, 2003).  This 
reaction appears to be the rate-limiting step of the whole sphingolipid biosynthesis 
process, and a key factor of the reaction is intracellular concentration of its substrates 
serine and palmitoyl-CoA (Pinto et al., 1992b).  This condensation generates a 
sphingoid base called 3-ketodihydrosphingosine (3-KDS).  3-KDS is reduced 
immediately by TSC10 into DHS, also called sphinganine (Pinto et al., 1992b).  DHS 
is then mainly hydroxylated into PHS at the C-4 position by SUR2 (Grilley et al., 1998).  
DHS and PHS can be converted into ceramide at the ER by ceramide synthase (Guillas 
et al., 2001; Schorling et al., 2001; Vallee and Riezman, 2005).  Then, ceramide is 
transported by vesicular and non-vesicular transport to the Golgi, where ceramide is 
transformed into the complex sphingolipids IPC, MIPC and M(IP)2C (Dickson and 
Lester, 2002; Sims et al., 2004).  To investigate whether TORC2 mediates synthesis of 
sphingolipid intermediates, sphingoid bases (3-KDS, DHS, and PHS) and ceramide in 
wild type, tor2ts, and avo3-1 cells were measured.  Similar to the inositol labeling, wild 
type and mutant strains were incubated at 37°C for six hours to inactivate TORC2 and 
then labeled with [3H]-palmitic acid or [3H]-L-serine for two hours.  During labeling, 
both radioactive molecules were taken up by wild type and TORC2 deficient strains 
without significant difference (data not shown).  Again, the amount of [3H] of the 
extracted lipids was counted by a scintillation counter, and same amounts of [3H] were 
loaded onto a TLC.   Palmitate labeling has demonstrated that both TORC2 deficient 
A B C
IPC
MIPC
M(IP)2C
DHS
Ceramide
*
*
*
*
37°C
W
T
tor
2
ts
av
o3
-1
IPC
MIPC
M(IP)2C
SUR1 CSH1 CSG2
IPT1
Ceramide
DHS
PHS
3-KDS
Serine + Palmitoyl-CoA
AUR1
LCB1 LCB2 TSC3
TSC10
SUR2
LAC1 LAG1 LIP1
24°C
Palmitate / PHS
PI
IPC
MIPC
M(IP)2C
Lyso-PI
DHS
Ceramide
*
37°C
W
T
tor
2
ts
av
o3
-1
W
T
tor
2
ts
av
o3
-1
77
Figure II-2-6
TORC2 deficient cells show downregulation in de novo sphingolipid biosynthesis.  (A) Schematic diagram of 
yeast sphingolipid biosynthetic pathway.  3-KDS: 3-ketodihydrosphingosine, DHS: dihydrosphingosine, 
PHS: phytosphingosine.  (B) [3H]-palmitate labeling was performed on wild type, tor2ts, and avo3-1 cells 
after a six hour incubation at non-permissive temperature.  Lipid extraction and separation were the same as 
in figure 4.  The asterisks indicate unidentified lipids.  (C) [3H]-L-serine labeling was performed on wild type, 
tor2ts, and avo3-1 cells.  The experimental conditions were the same as in (B). 
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strains accumulated palmitate and showed almost complete loss of synthesis of other 
sphingolipid metabolites (Figure II-2- 6B), suggesting that TORC2 mutants are unable 
to utilize palmitate.  Serine labeling showed a reduction in complex sphingolipids in 
TORC2 deficient cells (Figure II-2- 4C), consistent with the results of inositol labeling.  
In addition, ceramide in TORC2 deficient cells was slightly reduced, and sphingoid 
bases were undetectable (Figure II-2- 6C).  Since the accumulation of a substrate is 
expected when an enzyme is defective (Beeler et al., 1998; Haak et al., 1997; Schorling 
et al., 2001), the findings suggest that the first step, mediated by serine 
palmitoyltransferase, failed to occur in TORC2 deficient cells.   
TORC2 does not mediate the serine palmitoyltransferase activity at the 
translational, transcriptional, and post-transcriptional levels.   
The findings described above led us to investigate serine palmitoyltransferase.  The 
activity of serine palmitoyltransferase is the first and apparently rate-limiting step of 
sphingolipid metabolism (Obeid et al., 2002), therefore the reduction in sphingolipid 
biosynthesis in TORC2 deficient cells could be explained by defects in serine 
palmitoyltransferase.  A microarray dataset of tor2ts at 37°C for six hours revealed that 
TOR2 has 108 transcriptional readouts (that change more than two fold compared to 
wild type), but these readouts did not include the serine palmitoyltransferase 
components LCB1, LCB2, or TSC3 (data not shown).  There was also no significant 
difference in the protein levels of serine palmitoyltransferase components between the 
wild type and TORC2 deficient cells after a six hour incubation at non-permissive 
temperature (data not shown).  Physical interaction between LCB1 and LCB2 (Gable 
et al., 2000) was observed in the mutant strain as well as the wild type in the conditions 
where TORC2 deficient cells demonstrate reduction of sphingolipids (data not shown).  
In addition, no phosphorylation on LCB1 and LCB2 was observed by anti-phospho 
antibodies in both the wild type and the mutants, suggesting that TORC2 does not 
mediate the serine palmitoyltransferase activity at the translational, transcriptional, and 
post-transcriptional level.   
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Discussion 
We have shown that deficiency of TORC2 results in reduction of sphingolipid 
metabolites.  TORC2 mutants, tor2ts and avo3-1, as well as avo2 bit61 bit2 are 
synthetically lethal upon myriocin treatment at sub-lethal concentrations.  In tor2ts and 
avo3-1 mutants, sphingolipid metabolites are reduced.  The findings indicate that 
TORC2 is required for sphingolipid biosynthesis.   
TORC2 inactivation was induced upon shift of yeast cells to 37°C, a non-permissive 
temperature, for six hours. Under these conditions actin depolarization is observed 
(Schmidt, Kunz et al. 1996; Loewith, Jacinto et al. 2002).  Previous studies have 
shown that heat stress induces sphingolipid synthesis and de novo sphingolipid 
metabolites are required for heat shock response (Jenkins and Hannun 2001; Dickson 
and Lester 2002; Jenkins 2003).  However, TORC2 mediated sphingolipid biosynthesis 
is not likely to be influenced by heat stress.   First, as described above, reduction of 
sphingolipid biosynthesis only appeared in tor2ts and avo3-1, but not in torc1ts cells, 
suggesting that temperature sensitivity did not affect sphingolipid biosynthesis upon 
long term exposure to heat stress.  Second, while the induction of DHS and PHS by 
heat stress is transient and occurs within 30 minutes of heat stress onset (Dickson, 
Nagiec et al. 1997), reduction of sphingolipids was only observed after six hour of 
incubation at the non-permissive temperature (Figure II-2- 3).  Third, in the beginning 
of the temperature shift and for up to three hours, the growth curve and the ratio of actin 
depolarized cells in TORC2 deficient cells were not significantly different from the wild 
type (data not shown), suggesting that the initial adaptation to heat stress is similar to 
the wild type.  Taken together, TORC2-mediated sphingolipid biosynthesis is appears 
not to be a secondary result of heat stress response; therefore TORC2 is indeed required 
for sphingolipid biosynthesis.   
To display the phenotypes of TORC2 deficient cells takes at least six hours at the 
non-permissive temperature (Schmidt, Kunz et al. 1996; Loewith, Jacinto et al. 2002; 
Ho, Shiau et al. 2005).  Why does inactivation of TORC2 take such a long time?  
There is no certain answer yet, but it is plausible that TORC2 is very stable; therefore it 
takes a long time to denature its components.  Another possible explanation might be 
that the yeast takes up sphingolipids from the growth media during the first period of 
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incubation, and only when these are no longer available we can detect a reduction in 
intracellular sphingolipids.  We cannot exclude the possibility that the sluggish 
response is allele specific of the tor2ts and avo3-1 mutants, as we previously reported 
several allele-specific differences between TORC2 mutants.  For instance, four classes 
of tor2ts mutants were initially isolated, and each showed different colony size after 2.5 
days at 37°C (Helliwell, Howald et al. 1998).  Another mutant, tor2G2128R, 
demonstrateed an endocytic defect (deHart, Schnell et al. 2003), while tor2ts and avo3-1 
do not show endocytic phenotype (data not shown), suggesting that different mutants 
might be defective in different TORC2 functions.  It appears that TOR has multiple 
functions (Martin and Hall 2005; Wullschleger, Loewith et al. 2006), many of them still 
not well characterized; the different mutants might prove helpful in shedding light on 
these functions, as well as elucidating new readouts.  
How does TORC2 mediate sphingolipid biosynthesis?  So far, the regulation 
mechanism of sphingolipid biogenesis is not well understood.  The only conditions 
known to change sphingolipid synthesis are heat shock and substrate availability, both 
of which appear not to play a role in the crosstalk between TORC2 and sphingolipids.  
Our findings indicate that TORC2 is not likely to control the biosynthesis at the mRNA 
and protein levels of serine palmitoyltransferase.  Previous studies have shown that 
serine and palmitoyl-CoA are rate-limiting factors of the activity of serine 
palmitoyltransferase in yeast (Pinto, Wells et al. 1992) and in mammals (Hanada 2003).  
Therefore, a possible model is that TORC2 acts upstream of serine palmitoyltransferase, 
perhaps on its substrates.  However, the concentration of serine in TORC2 deficient 
cells is similar to the wild type at non-permissive temperature (data not shown), 
suggesting that the decrease in sphingolipid biosynthesis in TORC2 deficient cells is not 
due to a change in serine concentration.  Based on the finding that TORC2 deficient 
cells were not able to utilize palmitate (Figure 5B), it is speculated that TORC2 
deficient cells are defective either in the affinity of the serine palmitoyltransferase to its 
substrate palmitate CoA, or in acyl-CoA transferases, which convert palmitate to 
palmitate-CoA.  FAA1-3 are the yeast acyl-CoA transferases, and FAA1 prefers C12:0 
to C16:0 fatty acids, including palmitate, as substrates in vitro (Johnson, Knoll et al. 
1994).  The regulation mechanism of FAA1 and the other FAAs is not known.   
 81
Recently it has been proposed that SLM1 and SLM2 may act downstream of sphingoid 
bases, and are required for endocytosis during heat stress (Bultynck, Heath et al. 2006).  
SLM proteins bind TORC2 and are also required for actin cytoskeleton organization 
(Audhya, Loewith et al. 2004; Fadri, Daquinag et al. 2005), suggesting that SLM 
proteins participate in  TORC2 function.  Several observations in these studies 
support our findings.  First, deletion mutants of either slm1 or slm2 are sensitive to 
myriocin (Bultynck, Heath et al. 2006), consistent with our finding that TORC2 
deficiency induces myriocin sensitivity.  Second, heat stress-induced phosphorylation 
of the SLM proteins is independent of TORC2.  Heat stress and phytosphingosine 
treatment can induce phosphorylation of SLM proteins.  In addition, more than 90% of 
the heat-stress-induced phosphorylation of SLM proteins is inhibited by myriocin 
(Bultynck, Heath et al. 2006), suggesting that heat stress-induced phosphorylation of the 
SLM proteins is dependent on de novo sphingolipid biosynthesis, and thereby on 
sphingolipid-dependent protein kinases (Bultynck, Heath et al. 2006).  However, the 
phosphorylation levels of the SLM proteins in tor2ts are similar to the wild type after a 
four hour incubation at 38°C, indicating that the phosphorylation of the SLM proteins 
during heat stress is independent of TORC2 (Bultynck, Heath et al. 2006).  Notably, 
this finding also indicates that the heat stress response of tor2ts is similar to the wild type 
up to at least four hours.  
TOR is a central controller of cell growth, and cell growth implicates mass 
accumulation and surface expansion.  Since sphingolipids are mainly found in the 
plasma membrane (Patton and Lester 1991) and are required for cell growth (Dickson 
and Lester 2002), our finding that sphingolipid biosynthesis is mediated by TOR is 
therefore consistent with the previous findings, and presents further evidence for TOR 
function as a central controller of cell growth.  The detailed mechanism by which 
TORC2 regulates sphingolipid biosynthesis remains to be studied. 
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Materials and methods 
Strains, plasmids and media 
The complete genotypes of yeast strains used in this study are listed in Table I.  
Standard techniques and media were used (Sherman 1991).  Rich media, YPD and 
SDYE, and synthetic complete media with 2% glucose (SD) has been described 
previously (Sherman 1991).  
Spot assay 
Cells in mid-log phase were diluted in a ten-fold dilution series (10x, 100x, 1000x, and 
10000x).   4 µl of each dilution were spotted onto a YPD plate containing the 
indicated drags.  Growth was scored after two or three days at 24°C or the indicated 
temperature.   
Constructions of the domain-specific AVO3 deletion mutants 
The domain-specific deletion mutants of AVO3 were constructed by the two-step 
overlapping PCR method.  For the first PCR, two sets of primers were designed.  The 
N-terminus set was for amplification from -500 bp of the start codon of AVO3 to a 
nucleotide just before the domain to be deleted.  The reverse primer had a 40 bp 
extension at the 3’ end which complements a sequence just after the deletion site.  The 
C-terminal set was for amplification from just after the deletion site to +500 bp of the 
terminal codon.  The forward primer of the C-terminus set contained a 40 bp extension 
at the 3’ end which complements a sequence just before the deletion site.  With a yeast 
genome as a template, the first PCR was performed, and the PCR products were 
subjected to the second PCR.  The second PCR was done with the first PCR products 
as templates and primers.  The second PCR products were purified and inserted into 
the Saccharomyces/ E.coli plasmid vector YCplac33.  
Lipid labeling, extraction, and thin layer chromatography 
[3H]myo-inositol, [3H]palmitate, and [3H]serine labeling of yeast cells was performed 
for two hours at 24°C or 37°C.  Lipids were extracted, and analyzed by thin layer 
chromatography as described (Zanolari, Friant et al. 2000).  Briefly, 20 OD600 
equivalent of cells grown in SD media with [3H]myo-inositol or [3H]palmitate were 
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harvested, and labeling was stopped  by addition of NaN3/NaF mixture. The cells were 
broken by vortex with glass beads and chloroform/methanol/water (10/10/3) to extract 
lipids.  The supernatant were treated with 0.6 M NaOH at 30 min for at least 90 min 
and neutralized by 0.6 M acetic acid.  Lipids in the supernatants were purified by 
BuOH.  Same amounts of [3H], counted by a scintillation counter, were loaded onto a 
thin layer chromatography.   
Mass spectrometry-based lipid profiling 
The mass spectrometry-based approach to profile lipids was performed as described 
(Guan and Wenk 2006).  Briefly, 25 OD600 equivalent of cells were resuspended in 2 
ml of 95% ethanol/water/diethyl ether/pyridine/ammonium hydroxide (15:15:5:1:0.018) 
with internal standards.  Cells were broken by glass beads vortexing, and lipids were 
extracted and desalted by butanol extraction.  The sphingolipid-enriched fraction was 
subjected to mild alkaline hydrolysis to degrade ester bonds of glycerophospholipids.  
Lipids were then extracted with chloroform and dried under nitrogen.  For 
characterization/identification as well as quantification of lipid molecular species, 
electrospray-ionization mass spectrometry and tandem mass spectrometry was 
performed.  Obtained data sets were normalized, and warped against a reference set.  
Relative difference in the lipid compositions of the mixtures can be computed by 
calculating the logarithm (log10) of the ratio of ion intensities relative to control 
samples. 
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Table I.  Strains used in this study 
 
Strain  Genotype        
TB50a   MATa leu2-3,112 ura3-52 trp1 his3 rme1 HMLa leu 
BAS65-1B TB50a avo3-1 
SF43-1C  TB50a tor2::kanMX4 / pRS3143HA-TOR2 
SH121   JK9-3da tor2::ADE2 ade2 / YCplac111::tor2-21ts 
SH229  JK9-3da ade2 his3 HIS4 tor1::HIS3 tor2::ADE2 / YCplac111::tor2-29  
SW70  TB50a 3HA-TOR2 
RS38-4C  TB50a bit2::KanMX bit61::KanMX 
RS88-6D TB50a avo2::NAT bit2::KanMX bit61::KanMX 
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Conclusions and Perspectives 
Cell growth of yeast, or any organism, is an essential process for its life.  Therefore, 
understanding the mechanisms behind cell growth leads to better comprehension of life, 
one of the ultimate objectives of biology (and human beings).  In addition, cell growth 
is a critical step of cancer proliferation.  Many genes that encode proteins mediating 
cell growth are potential oncogenes, and thereby are possible candidates for drug 
discovery.  In spite of intensive efforts to identify and characterize growth-related 
genes and proteins, we still do not yet have a satisfactory explanation for several 
fundamental questions of cell growth (Broach 2005).  Cell growth is defined as 
accumulation of cell mass, but how does mass accumulation translate into information 
which cells can interpret, or how does a cell sense its size?  Nutrient limitation 
specifically blocks G1/S transition, but how do cells sense nutrient availability in either 
the intercellular or the extracellular environments?  And how do cells translate such 
information into cell cycle progression?  Is cell growth controlled by a central 
processing pathway, or by multiple signaling cascades?  Understanding of cell growth 
is still its way.  
Here, we describe a functional analysis of TORC2 signaling pathway, and reveal that 
TORC2, but not TORC1, mediates sphingolipid biosynthesis.  However, the control 
mechanism has not been elucidated.  Our findings include two major indications.  
One is a crosstalk between TOR and lipid biosyntheses, and the other one is the 
downstream networks of TORC2.   
TORC2 and lipid biosynthesis 
Cell growth implicates mass accumulation and surface expansion.  Therefore, cell has 
to coordinate both processes during cell growth.  Lipid synthesis, degradation, 
recycling, and transport have to be regulated in response to growth.  As a spatial 
controller of cell growth, TORC2 function on sphingolipid biosynthesis fits the idea.  
Then, does TORC2 mediate the other lipid biosyntheses?   
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For this, it is not clear answer yet.  However, our lipid profiling results of TORC2 
deficient cells showed reduction of phosphatidylserine (PS) levels.  This is the first 
indication that TORC2 might mediate phospholipid biogenesis.  PS is a membrane 
phospholipid that is ubiquitously present in membranes of eukaryotic and prokaryotic 
cells.  Unlike mammals, PS in yeast is the major phospholipid, comprising 34% of 
total phospholipid (Zinser, Sperka-Gottlieb et al. 1991).  Reduction of PS in TORC2 
deficient cells indicates downregulation of PS synthesis and/or up-regulation of PS 
lipase.  PS synthesis are carried out by PS synthase, which is one of the most highly 
regulated enzymes of phospholipid metabolism (Carman and Henry 1999).  So far, we 
can found several reports that mention regulation of PS synthase by transcriptional level 
(Carman, Iwata et al. 1982; Poole, Homann et al. 1986; Bailis, Poole et al. 1987; 
Homann, Bailis et al. 1987), by phosphorylation by protein kinase A (Kinney and 
Carman 1988), by the other phospholipids (Bae-Lee and Carman 1990), by sphingoid 
bases (Wu, McDonough et al. 1995), by inositol (Kelley, Bailis et al. 1988), by CTP 
(McDonough, Buxeda et al. 1995), and the availability of zinc (Iwanyshyn, Han et al. 
2004).  In construct, degradation of PS in yeast has been not well-studied.  
Phospholipases, PLB1, PLB2, and PLB3 can hydrolyze PS, but also 
phosphatidylinositol, which does not significantly change both in steady-state level and 
two hour labeling by [3H]-inositol (Figure ).  It remains to elucidate whether these 
factors are the link between PS synthase activity and TORC2.  We should note that 
although reduction of PS is observed, level of phosphatidylcholine (PC) is just slightly 
decreased.  Because PC is produced from PS, reduction of PC could be expected.  
This gap of two phospholipid species is also to be uncovered.   
The other lipid species found in yeast is ergosterol, yeast equivalent to cholesterol of 
mammals.  There is little evidence that indicate connection between TORC2 and 
ergosterol.  However, the genetic interactions of ergosterol genes and sphingolipid 
genes result in a requirement for both lipids for lipid raft formation, and therefore 
changes in composition of each lipid species should affect raft properties.   
, has strong genetic interactions with sphingolipid biosynthesis.  However, several 
reports have proposed that So there is a possibility that TOR mediate ergsterol 
biosynthesis via sphingolipid.  The genetic interaction of ergosterol genes and 
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sphingolipid genes probably result in that both lipids are required for the lipid raft 
formation and thereby changes in composition of each lipid species affect the raft 
property.   An erg26 temperature sensitive mutant that does not synthesize ergosterol 
at non-permissive temperature is defective in complex sphingolipid synthesis and 
hydroxylation of ceramide which SCS7 catalyzes (Swain, E sterol).  Another 
connection of sterol and sphingolipid has been shown in an erg24 mutant.  Although, 
this mutant is lethal, the additional deletion of the fatty acid elongase ELO3 can 
suppress (Veen, M 2005, ergosterol).  In contrast to the erg24 mutant, an erg6 deletion 
mutant is viable, but is synthetic lethal with an ELO3 deletion mutant (Eisnkolb, M  
2002).  A coordination of sphingolipid and sterol biosynthesis has also been described 
that down regulation of ergosterol biosynthesis pathway by azole anti-fungicides 
demonstrates significant reduction of expression of SUR2 and LCB1 (Bammert, GF 
2000, ergosterol).   
The TORC2 downstream networks 
Our findings indicate that sphingolipid biosynthesis is a novel downstream target of the 
TORC2 signaling pathway.  Interestingly, the other TORC2 readout, actin cytoskeleton 
organization and endocytosis, are also mediated by  sphingolipids, specifically 
sphingoid bases, via the mammalian PDK1 homolog PKH proteins (Friant, Lombardi et 
al. 2001; deHart, Schnell et al. 2002).  Furthermore, two known substrates of TORC2, 
YPK kinases and SLM proteins, are involved in actin cytoskeleton organization and 
endocytosis (Chen, Zheng et al. 1995; Roelants, Torrance et al. 2002; Schmelzle, 
Helliwell et al. 2002; Audhya, Loewith et al. 2004; Fadri, Daquinag et al. 2005; Kamada, 
Fujioka et al. 2005).  Although we did not see an endocytosis defect of tor2ts and 
AVO3-1 in our strain background, the piled evidences for a functional connection 
between actin and endocytosis and downstream networks of TORC2 (Figure ) point out 
that TORC2 is a controller of endocytosis.   
There are several evidence that support involvement of TORC2 in regulation of 
endocytosis.  Genetic and microscopic analyses have indicated that the transient 
formation of actin patches at the cell cortex is an important step in endocytosis.  
Screening mutants that are defective in α-factor uptake has resulted in isolation of 
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several genes related to actin cytoskeleton; ACT1, the only yeast actin gene; SAC6, 
encoding the F-actin cross-linking protein fimbrin, and SLA2, encoding an actin-binding 
protein important for polarization of the actin cytoskeleton (Kubler and Riezman 1993; 
Raths, Rohrer et al. 1993; Munn, Stevenson et al. 1995).  Deficiency of the Arp2/3 
complex, a highly conserved actin nucleation center for the motility and integrity of 
actin patches (Machesky and Gould 1999), shows abnormal and depolarized actin 
patches.  Temperature sensitive mutants of components of the Arp2/3 complex, either 
ARP2 (arp2-1) or ARC35 (end9), are also defective in uptake of uracil permease and 
α-factor, respectively, indicating that the Arp2/3 complex is also required for endocytic 
internalization (Munn and Riezman 1994; Moreau, Madania et al. 1996; Moreau, Galan 
et al. 1997).  There is strong correlation between genes whose mutation displays in 
actin cytoskeleton defect, i.e., depolarized actin patches, and genes whose mutations 
show endocytic phenotype (Engqvist-Goldstein and Drubin 2003).  These findings 
indicate that actin cytoskeleton organization is tightly connected to endocytosis; 
therefore it is very likely that TORC2 is involved in endocytosis event as well as actin 
cytoskeleton organization. 
So, if TORC2 indeed participates in endocytosis, which step of endocytosis could be 
regulated by TORC2?   
Endocytosis in yeast is supposed to occur at static sites marked by PIL1, LSP1, and 
SUR7 (Walther, Brickner et al. 2006).  It is unknown mechanism, but the early markers 
of endocytosis, clathrin, AP180, EDE1, ENT1, and ENT2 accumulates the site where 
PIL1 localize.  The next step in endocytosis is the recruitment of additional endocytic 
coat proteins SLA1, PAN1, END3, and SLA2, as well as the Arp2/3 activating protein, 
LAS17.  Up to this step, these protein markers are non-motile (Kaksonen, Sun et al. 
2003).  Consequently, LAS17 promotes actin polymerization at the plasma membrane, 
which is also regulated by type I myosin MYO5 and MYO3, and BBC1 from the 
perspective of (Anderson, Boldogh et al. 1998; Evangelista, Klebl et al. 2000; Mochida, 
Yamamoto et al. 2002; Soulard, Lechler et al. 2002; Soulard, Friant et al. 2005).  
During this step, invagination of membrane is supposed to occur, and proteins show 
slow movement.  The amphiphysin-like protein RVS161 and RVS167 are proposed to 
pinch off the endocytic vesicle (Breton, Schaeffer et al. 2001) and then actin 
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polymerization drives the vesicle inward.  This is followed by disassembly of the 
endocytic coat and associated proteins.  In this period, proteins are in fast movement, 
and the patches are moving away from their initial cortical position, toward the cell 
center (Kaksonen, Sun et al. 2003).  
TORC2 deficient cells display actin depolarization, indicating that actin assembly at the 
endocytosis site already begins.  Therefore TORC2 should mediate a step before the 
actin assembly.  A potential target of TORC2 is myosins I, encoded by MYO5 and 
MYO3.  Myosins I regulates actin assembly (Anderson, Boldogh et al. 1998), and is 
phosphorylated by YPK2 (Grosshans, Grotsch et al. 2006), which is a substrate of 
TORC2 (Kamada, Fujioka et al. 2005).  In this context, TORC2 activates MYO5 via 
YPK2, and progress endocytosis.  In contrast, TORC2 deficient cells could loose its 
kinase activity, and thereby be unable to activate myosins I to sustain endocytosis.  
Consistent with this, MYO5 temperature-sensitive allele shows a strong defect in the 
internalization step of endocytosis (Geli and Riezman 1996).  Another potential target 
of TORC2 is PIL1 and LSP1.  The proteins are involved in an immobile protein 
complex that localize at the cell periphery (Walther, Brickner et al. 2006).  These 
proteins are supposed to mark a site of endocytosis, and known to negatively regulate 
PKH and down stream pathways PKC1 and YPK1 (Zhang, Lester et al. 2004).   
If TORC2 is indeed required for endocytosis, it is possible that one of the upstream 
signals toward TORC2 is a cell cycle dependent, since endocytosis i.e., actin 
cytoskeleton are organized in a cell cycle dependent manner.  However, further studies 
on TORC2 would provide useful insights to answer the fundamental questions of cell 
growth, shown in the beginning of this session.   
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